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Summary of work. 
RNA molecules play a major role in cellular processes such as replication, 
transcription, and translation. As a result, RNA-based engineering methods 
have emerged as important tools in biotechnology. However, the structure 
and function of RNA depends on global interactions, which often prevents 
the use of a modular design strategy, particularly with allosteric 
conformations. Using RNA secondary structure prediction tools, 
computational methods can successfully design RNA switches that work in 
E. coli. The overarching aim of my research is to develop synthetic RNA 
switches that could be used for regulation and sensing of molecules in living 
cells.  
We have engineered RNA based synthetic signal transduction cascade 
consisting of a single RNA molecule (regazyme, an RNA chimera of an 
aptazyme with a riboregulator) that upon sensing a ligand (theophylline) self-
cleaves and releases a riboregulating small RNA. This small RNA binds to a 
cis-repressed mRNA allowing translation of a reporter protein. This system 
can be adapted to be induced by other ligands and can be used as a 
biosensor. I have also integrated a riboregulated RNA switch into the E. coli 
genome to study its behaviour at single-cell level. This reduces the 
transcriptional and translational noise in data collection to inform more 
accurate computational design of RNA regulatory units. We used 
computational design to engineer higher-order RNA-triggered riboregulators 
organized as a hierarchical toehold activation cascade. This has been 
studied in a single cell as well as in a population of E. coli cells. These RNA 
riboregulators can be used for construction of new, complex and portable 
synthetic gene circuits.   
In addition, I have engineered sense and antisense riboregulators consisting 
of the small RNA reverse complement of a known riboregulator. This 
riboregulator can transcribe two small RNAs from the same DNA template 
depending on the direction of transcription. These two small RNAs 
independently trans-activate translation of their cognate target genes and 
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both RNAs also silence each other by antisense interaction. We have also 
engineered an RNA-based tunable antiterminator, a TNA-derived adaptor 
that acts as a signal converter in a genetic circuit, converting a translation 
signal to a transcription signal (unpublished). I have engineered a minimum 
alphabet riboregulator that has only three nucleotides (GCU) that currently 
validating (unpublished).  
In order to explore the use of directed evolution for the engineering of RNA 
switches, I am developing an evolution-based system for generation and 
selection of new biomolecules. These evolved new biomolecules could be 
used in future medical applications such as molecular sensing. I have been 
using T7 and P2 bacteriophages as the basis for this evolutionary system. I 
have engineered the genome of the T7 phage with (regazyme, Riboswitch 
and riboregulators) using homologous recombination with marker-based 
selection. These engineered phages can be used to evolve new 
biomolecules such as other regazymes, riboswitches and riboregulators.  
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0.0 General Introduction 
Synthetic biology is an emerging interdisciplinary area which applies 
engineering principles towards design and construction of biological parts, 
devices and systems for useful biotechnological applications (Endy 2005; 
Khalil & Collins 2010; Qi & Arkin 2014). In past decades, a number of 
promoters (Alper et al. 2005), scaffolds (Dueber et al. 2009) proteins and 
RNAs (Pfleger et al. 2006); (Win et al, 2008) have been designed and 
characterized. There are currently a number of complex circuits including 
oscillators (Elowitz et al. 2000; (Stricker et al. 2008); (Danino et al., 2010), 
toggle switches (Gardner et al., 2000; Atkinson et al., 2003), riboregulators 
(Isaacs et al., 2004; Rodrigo et al., 2012; Na et al., 2013), riboswitches 
(Tucker et al., 2005; Blount et al., 2006) and biological logic gates (Tamsir et 
al., 2011; Moon et al., 2012) engineered  into a wide range of organisms. 
The goal of synthetic biology opens a new door to the engineers and 
biologists for the designing of a novel biomolecules, reprogram the cell, 
evolve the new medically applicable biomolecules (Khalil & Collins 2010). 
These engineered organisms could be useful for diagnostic, targeted 
therapy, such as cancer and to kill superbug. This reprogrammed cell would 
have many applications such as dynamic control on gene expression 
sensing of molecule. The cell regulators such as DNA, protein, RNA and 
DNA modifying the regulators control gene expression (Nielsen & Voigt 
2014). The reprograming cell or engineering genetic circuits are challenging 
because, genetic circuits should be robust, cell regulator should not be toxic. 
Cell regulators should also have fine tuning. The regulator should not interact 
with in cell and no cross talk with in cell and host cell. That’s we need to 
engineer novel regulatory circuits, and RNA switches to reprogram cell. 
Currently, the development of synthetic riboswitch, genetic circuits and 
related technologies is a high priority for the synthetic biology community 
because it allows programmable control over the cell. However, RNA 
synthetic biology is in its infancy, there will be more research to be done in 
near future in order to understand the function and mechanism of RNA 
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switches within the cellular systems. In the past decades, RNA was known 
as an information carrier molecule, carrying genetic information from DNA to 
protein. Recently, RNA has emerged as a key regulatory molecule and is 
now known as a highly versatile molecule with regulatory, enzymatic and 
structural roles in the cell. RNA can regulate major cellular functions such as 
replication, transcription, and translation.  
 
Figure 0.1 Explains Mechanism of central dogma (figure credit to wiki) 
It has important roles in post-transcriptional regulation, including gene 
repression and activation by using synthetic riboregulators, which can be 
explored for constructing novel regulatory circuits (Isaacs et al., 2004; 
Rodrigo et al., 2012; Na et al., 2013). To develop RNA switches RNA based 
circuits, different aspects of RNA function used that are described below. 
  
0.01 Base pairing functionality 
The base-pairing or antisense RNA regulation is primarily involved in the 
regulating by small non-coding RNAs present in bacteria (sRNA) and 
eukaryotes (microRNA) (Wassarman & Storz 2011).This RNA performs their 
function by hybridizing to target RNA by the base-pairing interactions. In 
eukaryotes, microRNAs are short RNAs (19-22bp) that bind 3’UTR region of 
mRNAs and regulate the transcript stability or translation efficiency (Lim et 
al., 2007). In prokaryotes, small RNAs (sRNAs) show promising role in the 
gene regulation for controlling of cellular physiology and growth. Recently, 
(Rodrigo et al. 2016) have engineered an antisense sRNA that could function 
in E. coli and one template could transcribe two small RNA that could 
activate two gene independently. Thus, base pairing has proved to be an 
essential element for gene regulation by sRNAs.  
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There are number of advantages by using sRNA, the specificity of RNA 
base-pairing being an important one, such that a single nucleotide mutation  
in riboregulator  can change specificity  and function (Davidson and Ellington 
2007). The advantages of RNA molecules allow them to adapt to form a 
regulatory sub-circuit that in turn could be linked together in cis, in trans and 
in multiple layers to create different synthetic biological circuits. These 
properties allow us to engineer RNA based circuits in E. coli. Some of these 
sRNAs use the RNA chaperone Hfq, which facilitates the binding of sRNA to 
target mRNA at faster rate than the ribosome and regulates the gene 
function (Sakai et al. 2014). 
 
 0.2 Binding functionality 
In addition to hybridizing with DNA and RNA in a sequence-specific manner, 
RNA molecule has high specificity of binding to proteins and ligands. This 
binding property of RNA can control cellular functions like transcription, 
processing, and translation. Researchers have designed a library of synthetic 
RNA aptamers and selected by SELEX (Systematic Evolution of Ligands by 
Exponential Enrichment). These synthetic aptamers can control the signal 
processing in cell, protein function, and gene regulation (Shen et al., 2015). 
These synthetic or natural aptamer can be specifically bound to their target 
(protein, RNA or ligand) and changed the conformation of RNA to activate or 
repress the gene expression. This allows us to use aptamers for medical and 
therapeutics applications. We have engineered a switchable ribozyme that 
emits an sRNA upon binding of theophylline which is called as regazyme. 
The emitted sRNA then specifically to the 5’ UTR of its target mRNA and 
changes the conformation of mRNA to open the RBS (Shen, et al. 2015). 
This exposure of the RBS allows landing of the ribosome and start the 
translation process. 
 
 0.3 Catalytic functionality 
RNAs catalytic activity was discovered in the year 1982 that catalyse the 
biochemical reactions which is known as ribozyme (Kelly et al. 1982). Natural 
and synthetic ribozymes can both catalysed the biochemical reactions. 
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Ribozyme catalyses the reaction in two ways the first is self-cleavage and 
second is trans-cleavage. Ribozymes also catalyse the RNA splicing, where 
they break a phosphodiester bond and rearrange it by reformation or ligation. 
Recent studies suggested that RNA splicing also present in prokaryotes. The 
circular RNA splicing in prokaryotes removes the intron and re-ligates the 
exons (Jeck et al. 2013) (Rostain et al. in revision) and this mechanism may 
protect against the RNA degradation (Arraiano et al. 2010). The 
hammerhead ribozyme is the smallest natural ribozyme regulating rolling 
circle replication in viroid’s by self-cleavage mechanism (Ellington et al. 
2006). These regulatory and enzymatic properties of sRNA attract the 
biologist to design new riboregulator, RNA switch, riboswitch and new 
ribozyme by computational and rational design with predictive behaviours. 
 
Figure 0.3 explains mechanism of aptazyme (adapted Kushwaha et.al., ACS synthetic 
biology 2016)  
 
0.4 Riboregulators (trans-activating riboswitches) 
In1986 Kozak discovered first riboregulator and first synthetic riboregulator 
has been built by Isaacs et al (2004) that allows us to design a novel sRNA-
based circuits with predictive functions. Riboregulator is a small regulatory 
RNA that responds to a signal nucleic molecule by Watson and Crick base 
pairing. The base pairing of riboregulator with RNA molecule changes the 
conformation and structure of target RNA and activate or repress the cellular 
reaction such as replication, transcription and translation. The sRNA base 
pairing with cis-repress mRNA (5’UTR) changes the conformation and opens 
the RBS that binds ribosome to translate protein (Isaacs et al. 2004; Rodrigo 
et al. 2012)  or repression, and also DNA replication (origin of replication 
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repression), base pairing with  complementary or  antisense RNA  repress 
the translation(Rodrigo et al. 2016.) 
  
Figure o.4 Explains the Mechanism of trans-activating riboswitch(riboregulator) adapted 
Kushwaha et.al., ACS synthetic biology 2016  
The translational riboregulator regulates translation by changing the 
conformation and make RBS accessible to ribosome to start the translation. 
Ribozyme based riboregulators regulate the ability of a catalytic RNA 
molecule to cleave a target nucleic acid sequence. A hammerhead ribozyme 
(Wieland et.al., 2008) RNA molecule is activated or inactivated depending on 
the change of the secondary structure that is induced by hybridizing a signal 
molecule such as a cognate DNA or RNA sequence.  
 
0.5 Riboswitches 
Riboswitches are the versatile RNA molecule typically found in the 5’ UTR 
regions of mRNA, where they control the gene expression by binding of 
ligand (Tucker & Breaker 2005). Riboswitch is also known as extracellular 
sensor of vitamins and derivatives (Sedlyarova et al. 2017). The riboswitches 
consist of two domains, an aptamer domain and an expression platform. The 
aptamer domain is a highly specific structure that selectively binds to the 
target ligand or metabolite and change the conformation. 
 The expression platform change conformation after binding metabolite 
activated or repressed gene expression. Riboswitch have a wide a range of 
small metabolite, ligand and they regulate transcription, translation, splicing 
and RNA stability. Currently, the riboswitch is used for developing new 
antibiotics, designing new molecular sensors and engineering synthetic 
circuits.  
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Figure 0.4 Explains the Mechanism of ligand activating riboswitch adapted Kushwaha et.al., 
ACS synthetic biology 2016  
My overall goals of PhD study to use computational and rational design to 
engineer novel trans-activating riboswitches (RNA switches) in E. coli. The 
ccomputational methodologies principally rely on the Watson-Crick 
interactions, whereas this is not adapted to in vivo operations where RNAs 
are unstable. Recently, Jaramillo’s Lab has reported a fully automated 
design methodology and experimentally validated synthetic RNA interaction 
circuits working in E. coli. Starting with well-defined structures of all single 
species of RNA, our aim to minimize the free energy and the activation 
energy of complex formations by proposing an objective function, using a 
Monte Carlo simulated annealing algorithm has been used. It has been 
validated by engineering a synthetic riboregulator which is able to trans-
activate the translation of a cis-repressed gene. To this end, we have 
successfully engineered novel  trans-activating riboswitches in E. coli at 
multiple layers such as single component riboswitches and multi-components 
riboswitches that function independently and also in combination with 
transcription regulation to create a complex logic gate circuit.  
 To This end for thesis 1st chapter, we have been engineered RNA based a 
tuneable antiterminator system. The sRNA responds to a signal directly 
regulates the control of structure and conformation of cis-repress mRNA and 
RBS. The RBS regulates the translational control of transcription and 
termination. 
In the first chapter of thesis, we have engineered sRNAs (act as a signal) 
that behave as a translation-transcription coupling adapter (TTCA element). 
Here, the synthetic TNA derived adaptor acts as a signal converter in a 
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genetic circuit, converting a translation signal to a transcription signal by 
closely interfacing the ribosome and the RNA polymerase(Liu et al. 2012)     
Transcriptional terminators in the prokaryotes are of two types, Rho 
dependent and rho independent. Rho independent termination is responsible 
for 80% termination events in bacteria. A terminator is AT rich DNA 
sequence in bacteria. The RNA Polymerase (RNAP) has two regions to 
pause at terminator region. First mRNA transcript of stem loop region of 
terminator makes hairpin loop in bacteria and the RNAP unable to scan 
hairpin and slow down as well as ultimately pause. The second terminator 
region has a poly(U) repeat sequence, at which the RNAP back tracks. This 
hairpin structure and poly(U) repeat sequence destabilizes the transcription 
elongation complex and RNAP drops off from the DNA sequence to finally 
terminate the transcription.  
In electrical engineering, digital circuits are organized into Boolean gates that 
establish the basic logical operations. In the second parts of thesis we have 
built single component a trans-activating riboswitch in E. coli. For 
reprogramming cell, we need more complex and robust system. However, in 
previous implementations of cellular logic, complex gates such as XOR gate 
(ambisense riboregulator) have required the layering of multiple genetic 
circuits, thus necessitating substantial efforts in circuit construction and 
tuning. We have taken advantage of our computational de novo design of the 
sRNA based riboregulators to design ambisense riboregulator with two sRNA 
signals. This was attempted through the base pairing between two 
complementary riboregulators, leading to an output of 0 when all inputs are 
either 1 or 0 (Rodrigo et al. 2016). This could be used for the conditional 
activation or repression of targeted gene. In this part we are able to 
transcribe two RNA signal (two riboregulator) depends on polarity of DNA 
and promoter direction. These two small RNA signals able to activate two 
different gene independently. Aim of to engineer this type of system is to 
reduce metabolic load on the cell. This end we are also able to engineer 
trans-activator riboswitch that having three nucleotides only. 
The above properties allow us to engineer genetic circuits that are useful in 
synthetic biology.  In third part of thesis, we have engineered a trans-acting 
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multicomponent riboswitches (cooperative) that used two sRNAs signal. The 
sRNA based cooperative riboregulator that performs an AND gate operation 
on the input signals: that returns a 1 only when all inputs are 1. A pLtetO1 
promoter that controlled riboregulator which can be exposed the 5’-UTR cis-
repressed RBS of the mRNA to allow the translation of the reporter protein 
GFP. These switches regulate the mRNA translation by controlling access of 
ribosomal machinery to the mRNA. The most common point of control is 
translation initiation, when the 16S rRNA anti-SD interacts with the RBS to 
form the translation initiation complex. Cooperative sRNA-mediated 
activation is also possible in mRNAs where a structured 5′UTR occludes the 
RBS in the OFF state, and only allows RBS access upon the conformational 
change which is induced by the two sRNAs signal binding cooperatively 
(Rodrigo et al. 2017). The cooperative regulation is common in proteins to 
control many biochemical reactions. We have designed cooperative 
regulation in bacteria using synthetic sRNA signal, which to our knowledge 
has not been previously designed and tested in E. coli. However, in 
eukaryotes cooperative microRNA based regulation has been previously 
reported (Schmitz et al. 2014).  
In this section additionally, we have explained the orthogonality. The 
orthogonality results explain robust system and does not have cross talk with 
other RNA and host cell. To this end, we have studied the orthogonality of 
our RNA triggered riboregulators and riboregulators engineered in host lab 
recently. (Rodrigo et al. 2017., Rodrigo et al.2012). Our data explain that our 
system is robust and no crosstalk with other RNA and host cell. Previously, 
we have engineered and characterized a new RNA molecule which is 
regazyme (Shen et al., 2015). We have fused riboregulator RAJ11 with 
theophylline aptamer, this riboregulator is active in presence of theophylline. 
In the presence of theophylline, it can change the conformation and get 
cleave and release riboregulator. This riboregulator binds to cis-repress 
mRNA change the conformation that allows RBS to land ribosome and 
obtained expression of GFP.  
In order to have consistency results and less metabolic burden on host cell, 
we have integrated riboregulator (RAJ11) into genome of E. coli by the site-
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specific recombination (Kuhlman & Cox 2010) and studied at single copy(Lee 
et al. 2016).  
Currently, directed evolution is a fast and robust approach for evolving 
biomolecules in changing environmental conditions and allow us to fit in that 
conditions(Esvelt et al. 2011). We have used interactive cycles that we could 
find best fitted molecules with higher stability. We have used T7 
bacteriophage as a tool for directed evolution of RNA molecules, RNA 
circuits, riboswitch and protein molecules. We have designed and 
characterized three recombinant T7 bacteriophages including (T7riboswitch, 
T7 regazyme and T7 sRNARAJ11 bacterteriophage). This has a number of 
future applications for controlling of multidrug resistant bacteria, gene 
therapy and diagnostic.  
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   AIM of work 
 
• Engineering of a tunelable antiterminator riboswitches 
 
• Engineering single component advanced riboswitches 
 
• Engineering multi-component advanced riboswitches 
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Chapter 1 
 
Engineering of tuneable antiterminator  
riboswitches 
 
 
 
 
Schematic of tuneable antiterminator system 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 
1.1 Abstract. In prokaryotes, transcription and translation both reactions 
proceed simultaneously. We exploit this property of E. coli to engineer a 
system that converts translational signal into transcriptional signal. Here, we 
report a trans-activating small RNA (sRNA) that binds to cis-repress mRNA 
and opens the RBS that allows access of ribosome. This landing of the 
ribosome at the RBS initiates the translation and initiation of translation 
prevents the hairpin formation of newly transcript mRNA at termination 
region and also prevents back tracking of RNA polymerase. This allows 
transcription is continuing on terminator region and reporter protein GFP is 
expressed. The efficiency of converting translational signal to transcription is 
tightly regulated by strength of RBS. This type regulation will open new way 
of gene regulation and could be important in synthetic biology.  
 
1.2 Introduction 
The central dogma is one of the key components of cellular systems. Gene 
regulation at the transcriptional and posttranscriptional level play a vital role 
in synthetic biology. Recently, the synthetic biologists are more interested in 
riboswitches and small non-coding RNA due to easy to design, use and 
characterize in living cells. The transcription  process is the key regulatory 
step in gene expression where RNA Polymerase binds to a promoter 
sequence and start the transcription at the transcription start site (TSS). In 
the E. coli transcription and translation processes are simultaneously started. 
Once the ribosome binds on the ribosome binding sites and it starts the  
protein synthesis. Transcription termination has important role in  the cellular 
mechanism as follows-  
It prevents  un-useful  transcription of downstream gene  and interference of 
antisense  RNA (Ray-Soni et al. 2016). 
1. The  recycling of RNAP is free for efficient gene expression.  
2. The termination is also prevents  collisions with replication machinery. 
This  collision can cause double strand break in the DNA (Ray-Soni et 
al. 2016). 
3. Transcription termination also specify structure and polarity of 3’ of 
RNA.  
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Bacteria have  three  type  mechanisms  of transcription termination  
1. Intrinsic termination is regulated  by hairpin structure  and RNAP 
back tracking. 
2.  Rho dependent (homohexameric protein)  protein binds to 
transcribe RNA and move along the RNA and  hydrolyses ATP to 
drive RNA translocation and RNAP-RNA-DNA complex dissociate 
finally release RNA (Ray-Soni et al. 2016)  
3. Mfd protein an ATP dependent  DNA translocase that binds to 
double strand  DNA (rewinded DNA after transcription) just  behind 
transcription bubble. This Mfd inhibits  NTP polymerisation and 
nascent RNA chain dissociate (Park et.al., PNAS 2006). 
A termination signal induces a rapid and irreversible dissociation of 
the nascent RNA from RNAP and DNA. In E. coli rho independent 
terminator  structure composed of GC rich (5-9) nucleotide  and 3-5 
nucleotide stem loop followed by 7-9 poly(U) tail. The Rho 
independent  transcription termination involves the formation of an 
RNA hairpin in  the nascent RNA (Park et.al., 2006). They  reported 
that palindromic sequence should  be sufficiently long to form an RNA 
hairpin to destabilise the  RNA-DNA hybridisation. If the palindromic 
sequence is not sufficiently long then a hairpin would not form and 
transcription will go on continuously on termination (Li et.al., 2015). 
The hairpin formation  of  mRNA transcript may disrupt  the RNA-DNA 
hybrid.   
There are two key factors responsible for transcription termination at nascent 
mRNA in E. coli. The first key factor is terminator sequence forms a stem 
loop sequence and newly transcribed mRNA that make hairpin loop and 
regulate the RNAP. The second factor is terminator region that contains a 
poly(U) sequence, and RNAP  read  this sequence as an error that allows 
start back tracking as well as transcriptional elongation complex dissociate; 
resulting in the eventual dislocation of the RNAP from DNA. 
In our de-novo design of a trans-activating riboswitch, small RNA acts an 
external signal regulated by PLlcacO1 promoter and the 2nd Part is the cis-
repress mRNA controlled by constitutive promoter BBa_J23119. The 
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external signal sRNA bind to expression region of the part of cis-repressed 
mRNA  of riboswitch  which opens the conformation and activates it. 
In our newly created de-novo tuneable antiterminator system, we have 
designed a 5’UTR that contains a cis-repress RBS and the start codon ATG 
just before terminator sequence that is regulated by constitutive promoter 
BBa_J23119. This cis-repress RBS is tuned by small RNA signal (Rodirgo 
et. al., 2012) regulated by PLlacO1. Normally, the constitutive promoter 
(BBa_BBa_J23119) always expresses 5’UTR but it forms secondary 
structure and sequester the RBS that will not allow for translation. However, 
in the presence of inducer (IPTG) the PLlacO1 promoter expresses the 
sRNA signal that hybridizes with cis-repress 5’UTR and changes 
conformation and opens the RBS to bind ribosome. In bacterial systems, the 
transcription and translation are proceed simultaneously. The landing of 
ribosome at the RBS and initiation of translation prevents hairpin formation at 
the stem loop sequence. This prevents hairpin formation and if RNA 
polymerase has ribosome and translation just behind poly(U) sequence then 
RNAP does not read as an error. It prevents backtracking and transcription is 
continued on terminator sequence and GFP of ORF2 is expressed.  
We have engineered sRNA signal system  that works as a translation-
transcription coupling adapter (Liu et al. 2012). In our system, sRNA binds 
and cis-repressed 5’UTR to open the RBS for ribosome landing. The landing 
of ribosome on RBS initiates translation. This initiation of translation, 
continues transcription elongation at the terminator region by preventing 
backtracking of RNA polymerase. This preventing of backtracking by RNAP 
prevents hairpin formation of transcript at terminator region (Cambray et al. 
2013; Liu et al. 2012). This continued transcription of the terminator region  
allows transcription of ORF2 and the subsequent translation of reporter gene 
(super folder green fluorescent protein with degradation tag  sfGFP-LAA). 
The transcription elongation rate is tightly regulated (Proskin et al., 2010) by 
the rate of translation initiation. Increasing and decreasing the rate of 
translation initiation (ribosome  binding on RBS or RBS strength) directly 
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affects elongation of transcription (RNAP speed). 
We have also engineered a library of this novel RNA signal-based 
transcriptional attenuation regulator based on the rho-independent 
terminators in bacteria. The TTCA constructions contain two separate parts 
that is expressed from a single plasmid. Firstly, an sRNA signal ( RAJ11) is 
placed under the control of a PLlacO-1 promoter. Secondly, a cisRAJ11-
Terminator-RBS-sfGFPLAA mRNA is transcribed under the control of a 
constitutive promoter (BBa__J23119). The inducible sRNA RAJ11 activates 
the expression of GFP from the mRNA by binding to its cisRAJ11 region. 
The terminator region in mRNA must be flanked by 5’ ATG codon and a 3’ 
TAA codon, however the structural region of the terminator is variable (i.e. 
we have used any of the terminators B1002, tonB, rrnB, T21, Tfur, rev-Tfur, 
T500 and synthetic terminator). We designed the library of different 
terminators and characterized in different riboregulators 12 (Isaac et al., 
2007), Collins toehold switch (Green et al., 2014) and Gallivan riboswitch 
(Lynch et.al., 2007). Downstream of the terminator region is another RBS, a 
start codon and the reporter gene (sfGFP with the LAA degradation tag 
showing in Figure 1.1). When translation is activated by the sRNA, 
transcriptional termination at the terminator poly(U) is prevented by the 
ribosomes that block the backtracking of the RNA polymerase. 
 
           Figure1.1 Design of antiterminator RNA switch Plasmid 
Figure 1.1. Showing the design of a tuneable antiterminator plasmid. The promoter  PLlacO1 
(IPTG inducible) controlling  sRNARAJ11 and withT500 the terminator. The constitutive 
promoter BBa_J23119 controls cis-repress 5’ UTR-RBS and ATG. I fused terminator with 
stop codon and then RBS2 and reporter protein sfGFP-LAA. 
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Figure1.2 Schamatic TNA system 
Figure1.2. The mechanism shown in figure, In absence of IPTG, mRNA is transcribe but the 
RBS is not exposed  and the mRNA makes a hairpin loop at the terminator region. The RNA 
polymerase unable to read and pause. In the presence of  IPTG, PLlacO1 promoter gets 
activated and  sRNA is transcribed. The sRNA binds to cis-repress mRNA and change the 
conformation to expose RBS.  The Ribosome land on RBS and  prevent backtracking of 
RNA polymerase and transcription continue at terminator sequence  resulting reporter 
protein is expressed. 
 
1.3 Results and discussion  
We have characterized our anti-terminator by population level by 
Fluorescence plate reader, RT-PCR, Flow-cytometry and microfluidics 
analysis to study single cell dynamics. These results are showing in the 
below. 
 
1.3.1 Gel assay.  
Electrophoretic analysis of RT-PCR showing GFP expression with induction 
of IPTG and without induction of IPTG.  As showing in figure1.3A primer of 
GFP region and figure 1.3B Showing, no GFP expression without induction.  
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Figure1.3 Design and RT-PCR gel results of antiterminator RNA switch 
Figure1.3A Schematic of B1002 terminator and sfGFP and primers1 and primer2. 
Figure3.3B showing RT PCR results in gel. The Gel band showing in presence of sRNA 
signal gel band is sharp. This shows in presence  IPTG  promoter PLlacO1 is activated and 
sRNA transcribed. This sRNA activates cis-repress mRNA and and transcription continue on 
terminator reason and reporter protein is expressed. We isolate total RNA  in two conditions 
(none and IPTG). 
 
 We made cDNA and amplified  with sfGFP primer1 and  primer2. The PCR 
product was run on a 1% agarose gel with 100bp Plus ladder (Thermo-
fisher). We have sharp band in presence of sRNA (IPTG) and light band in 
absence of IPTG. Ideally in the  absence of IPTG there should not be an 
expressed  band, but the system is leaky as such. 
In the down table1 showing the list of terminators with their sequence  and 
free energy of activation. We also explains the RNA secondary structure of 
terminators used in our research. The mRNA fold online free software used 
to predict  secondary structure. We used library of terminators, the figures 
showing structure and sequence 
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Table1: Sequence and DG of different terminator 
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Figure 1.4A showing structure of hairpin and stem loop. 
 
1.3.2 Fluorimeter characterization results  
We have characterized the antiterminator system MG16555Z1 and also 
cross-checked results in Dh5alphaproZ1 E. coli strains. We have used a 
library of different terminators (B1002, Ttonb, TT21, T500, Rev-TFUR and 
Tfur. We have also engineered a library of same terminators based on 
template of previously published (Isaacs et al., 2007) and toehold Collins 
Toehold RNA switch. Additionally, we have engineered TNA circuits TNA31 
(a trans-activating riboswitch-based cascade), additionally also   tested our 
system in riboswitch (Arkin TNA system).  Double riboswitches (theophylline 
and adenine) based feed forward (cascade) also designed and constructed 
and characterized in E. coli., to make TNA based cascade system.   
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Figure1.4 B Design and Results of different terminator 
 
Figure 1.5 Above figure showing results of antiterminator. The results are in two conditions 
(0 and IPTG.) In the absence of IPTG PLlacO1 promoter is not active and no small RNA 
transcribed finally no GFP expressed. I have characterized library of terminator.  
   
Results of RAJ11 based TNA system. As shown in the figure 1.4B we have 
characterized different terminator (B1002, T500, rev-Tfur, T21, Ttonb, and 
Tfur. We have characterized in two conditions (0 and IPTG). As shown in the 
figure we get the expression in presence of IPTG. In the Presence of IPTG 
PLlacO1 gets activates and sRNA is expressed. This sRNA binds cis-
repressed mRNA and change conformation and makes activates. We have 
characterized library terminators all have different activation fold because all 
having different stem loop and hairpin structure. 
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1.3.3 Single cell dynamics of TNA B1002 terminator 
To further explore a tunable anti-terminator behavior of the system at the 
single-cell level, we have performed a time-dependent characterization of 
system TNA B1002 and TNA B1002 (Theophylline riboswitch) using the 
microfluidic lab-on- chip devices (Figure 1.5). This allowed us to monitor GFP 
expression in individual cells under a varying concentration of inducers IPTG.  
 
                  Figure1.5 Sigle cell dynamics of B1002terminator 
 
Figure1.5Figure showing single cell dynamics of B1002 terminator in presence of inducer 
IPTG and absence of IPTG. Single cell tracking of fluorescence GFP expression in arbitrary 
fluorescence units (AFU)] in one micro chamber of the microfluidics device under time-
dependent induction with IPTG (1mM) for system B1002 in Dh5alphaproZ1. A square wave 
of IPTG inducers with period 8 h (i.e., 4 h induction and 4 h relaxation) was applied. The 
solid and dashed lines (in blue) correspond to the mean and plus/minus standard deviation 
over the cell population. Sulforhodamine B was used to monitor the inducer time-dependent 
profile (in red) 
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1.3.4 FACS data for TNA system 
 
Figure1.6 FACS results of TNA system 
Figure1.6. The Flow cytometry characterization results of different terminator. The left side 
showing scatter plot and right-side value showing value. 
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1.3.5 Tunability with RBS 
The transcriptional control by transcription tune with RBS. We have 
generated an RBS knock out. We made construct with weak RBS deleted 
RBS. These controls were characterized in MG1655Z1 cells in two 
conditions (0 and IPTG). The results show that weak RBS gave a less GFP 
expression. The construct deleted RBS gave, no expression in both 
conditions (0 and IPTG). These results suggest that landing of ribosome 
prevents the hairpin formation and backtracking of RNAP. The weak RBS, 
ribosome unable to land on all transcripts and less transcriptional signal 
converted to translation. In the deleted RBS, there are no ribosome landing 
and no expression. 
 
 
Figure 1.7 TNA results tuning with RBS strength 
Figure 1.7 The above figure showing antiterminator results of RBS tuning. The weak RBS 
work as a weak antiterminator. The RBS deleted system having no expression in presence 
of RBS and absence of RBS. These results explaing that initiation of translation prevents 
hairpin fromation and backtracking of RNAP.   
 
1.3.6 Results of weak terminator (spacer) 
As shown in figure 1.8, we have mutated the terminator and kept the same 
amino acids. The ideally, we want test weak poly(U) (as reported in literature 
mutation in poly(U) decrease terminator efficiency (Sedlyarova & Nudler et. 
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al., 2016) but in our case same amino acids also synthesized. Our 2nd 
control, we have completely disrupted the hairpin and poly(U) that 
synthesized different protein as well. We have characterized both control 
with DT(terminator deleted) E. coli MG1655Z1 cells in both possible condition 
(0 and IPTG). As the results shown in both condition system gave the 
expression but the system poly(U) and hairpin and DT was showed very high 
expression, even in absence of IPTG. 
 
 
Figure1.8 Sequence and structure of Poly(U) mutate terminator 
figure 1.8 (A) A poly(U) mutated but stem loop is same, but gene expressing same 
protein. The figure 1.B poly(U) and stem loop both are mutated. Terminator also 
encoding different protein. The total GFP expression is increase, because terminator 
not inhibiting.  The 3rd control terminator is removed this is also giving total more GFP. 
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Figure1.8B Results of B1002 terminator mutation 
 1.3.7 ATG and stop codon knock out 
 We have made knock out of ATG and stop codon. We have inserted 
the AAG in place of ATG and stop codon (TAA) in place of ATG as 
shown in figure1.9. These knock out construct were characterized in E. 
coli MG1655Z1 in both condition (0 and IPTG). The results in the figure 
shown that total expression is increased in ATG Knockout but observed 
the similar activation fold. The argument is ATG and terminator is very 
closed. Once ribosome is land on RBS and translational initiation 
complex cover the region of terminator and it prevents hairpin formation 
back tracking of RNAP and transcription continue on terminator 
sequence. The 2nd argument is that newly transcribed mRNA is too 
small in size and it is unable to form hairpin formation. We need a 
minimum length of nascent mRNA to form proper hairpin and 
termination of transcription. 
We have constructed more control in order to support this argument. We 
have inserted some spacer (30 and 45 base pair) between (ATG and 
terminator) in both condition ATG and DATG construct as shown in the 
figure 1.9. We transformed these constructs into E. coli MG1655Z1 
strain and characterized in both possible condition (0 and IPTG). The 
results shown in figure 1.9, the ATG knock out have no expression 
when we inserted the spacer. But wild type (without knockout) express 
in presence of IPTG.  
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Figure1.9 Results of ATG and ATG/stop codon knock out 
Figure.1.9 Above results showed ATG knockout and stop codon knock out, not change the 
results. The terminator and ATG is to close and Translation initiation complex prevent 
hairpin formation and backtracking and transcription continue on terminator region.  
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Figure1.10 Results of DATG/spacer 
Figure 1.10 The resuts showed that after insertion of  30 bp and 45 bp spacer, no GFP 
expression in presence and absence of IPTG. These results explained that after ATG 
knockout (ATG mutated by AAG) not giving any expression.  
 
1.3.8 Synthetic translational to transcription control by Isaac 
riboregulator 
 In order to have more consistency in results, we additionally design a 
tuneable antiterminator system based on Isaac riboregulator (Isaacs and 
Collins 2006). This design is the similar as our RAJ11 based design. In this 
design small RNA (RR12) controlled by PLlacO1 promoter. The Promoter 
BBa_J32119 control 5’UTR -RR12 that is cis-repressed. We fused ATG and 
Terminator just after 5’UTR and then 
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Figure 1.11 showing design of antitermination system based on Isaac riboregulator. We 
constructed this system in B1002, Ttonb, rev-Tfur and Tfur.   
 
Figure1.12 results of Isaacs riboregulator and riboswitch 
Figure1.12 Reporter protein sfGFP-LAA. We characterized these systems in MG1655Z1 in 
two conditions (none and IPTG). Our explain that in presence of IPTG small RNA bind to cis-
repressed 5’UTR change conformation and open RBS and start expression of GFP. 
 
The above results explaining that our a tuneable antiterminator system also 
working Isaac’s riboregulator system. My lab colleague Dr. Michel also tested 
this system in toehold switch developed by (Green and Collins 2014). 
 
1.3.9 Synthetic translational to transcription control by RNA 
cascade 
 Our goal to engineer more robust and complex system that we engineered a 
cascade where one RNA signal regulates multiple RNA. We engineered a 
more complex system, where small RNA RAJ11 activates small RNA RAJ31. 
This small RNA 31 activates cis-repressed mRNA and expressed GFP.  The 
design is shown in the figure. The small RNA-RAJ11 is regulated by PLtetO1 
promoter. This promoter is activated by inducer aTc (100ng/ml). After 
induction of aTc Promoter gets activated and sRNARAJ11 synthesized. This 
small RNA-RAJ11 binds to cis-repressed RAJ11 and, regulated by 
constitutive promoter BBa_J23119. This cis-sRNA31 get activated after 
binding sRNARAJ11. This activated sRANA-RAJ31 and it bind cis-repressed 
mRNA31 and make it activate to express GFP reporter protein. 
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Figure 1.13 Trans-activating TNA 31 RNA cascade 
 
Figure1.13 The above figure showed the schematics of design. After induction of aTc 
PLtetO1 promoter and get activated and   sRNA-RAJ11 transcribed.  The lower left figure 
showing expression of GFP in four conditions (0, aTc, IPTG and aTC+IPTG). The maximum 
GFP is expressed in Presence of aTc+ IPTG. The system is also leaky that GFP is 
expressed in IPTG induction. 
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1.1.10 FACS results of TNA 31 circuits 
 
                       Figure 1.14 Results of TNA 31 cascade. 
Figure 1.14 showing FACS results in all four condition (0, aTc, IPTG and aTc+IPTG). The 
GFP value also maximum in presence of aTc+IPTG both inducer present. 
We characterized TNA 21 cascade in MG1655Z1 strain in all foour 
conditions (0, aTc, IPTG and aTc+IPTG). The floeimeter and FACS both 
results explaing, no activation in (none) and aTc induction. We got 
actation in IPTG and aTc+ IPTG. We should not have activation of 
reporter protein in presence of IPTG, but our system is leakey. 
 The TNA cascade  system was leakey that we designed spacer to 
reduce the translational rate. We have designed 4  spacers ( 6bp, 9bp, 
12bp and 15bp) which is inserted using the golden gate cloning. We 
have transformed into E. coli MGZ1655Z1 strain and charecterized  
using the 4 conditions ( 0 , aTc, IPTG and aTc+IPTG). 
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Spacing before ATG reduce translational rate  
 
 
Figure 1.15 Results of spacer 6, 9, 12, 15 TNA 31 cascade 
Figure1.15 The above is characterization results of TNA31 circuits in MG1655Z1. The 
leakiness of system is reduced and system giving better activation fold. 
To explore more possibility, we have designed more cascade based on 
the Isaacs RNA-RR12. Designed is shown in figure. The design is the 
similar as TNA31 cascade. 
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Figure1.16 Design and results of RNA cascade of RR12 and sRNARAJ31 
 
We characterized TNA-RR12 cascade in MG1655Z1 in all four 
conditions (0, aTc, IPTG and aTc+IPTG). This system also not having 
any activation in 0 and aTc but having with IPTG. The system having 
maximum activation in presence of both inducers. But IPTG also having 
so this system is also leaky. 
 
1.1.11 TNA system based on riboswitch and cascade 
In our above antiterminator riboswitch, the external signal is the small 
RNA that is present in trans. The trans activating small RNA signal 
activates cis-repressed mRNA by binding of sRNA. In this design 
external signal is theophylline and bind to aptamer domain of mRNA 
and change the conformation open RBS and make it active. In this 
design riboswitch is activates with external signal theophylline. We used 
theophylline riboswitch (Lynch and Gallivan et.al.,2007). Theophylline 
bind to aptamer change the conformation and get   activate. 
The TNA system we also tested in other riboregulator such as Isaac 
(RR12), theophylline riboswitch, and our recently published regazyme 
(Shen et al., 2015). The results are shown below. This system we 
obtained very high activation fold in Gallivan riboswitch. 
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Antiterminator cascade based on theophylline riboswitch 
 
 
Figure1.17A Design of Theophylline based antiterminator 
 
 
Figure1.17A Results of Theophylline based antiterminator 
 
1.1.12 Single cell dynamic of Theophylline riboswitch TNA system 
The theophylline riboswitch (Lynch et al.,2007) based antiterminator 
system was characterized in microfluidics to study single cell dynamics. 
The system is studied in two conditions (none and theophylline. In 
presence of theophylline system activate GFP reporter protein.  
 
 
 
 
 47 
 
 
 
Figure1.17C Single cell dynamics of theophylline riboswitch based 
antiterminator RNA switch 
Figure1.17C showing single cell dynamics of B1002 terminator in presence of inducer 
theophylline and absence of theophylline. Single cell tracking of fluorescence GFP 
expression in arbitrary fluorescence units (AFU)] in one micro chamber of the microfluidics 
device under time-dependent induction with theophylline (6 mM) for system TNA B1002 
Galivan riboswitch in MG1655Z1. A square wave of theophylline inducers with period 8 h 
(i.e., 4 h induction and 4 h relaxation) was applied. The solid and dashed lines (in blue) 
correspond to the mean and plus/minus standard deviation over the cell population. 
Sulforhodamine B was used to monitor the inducer time-dependent profile (in red) 
 
We additionally study single cell dynamics of Gallivan riboswitch based 
antiterminator.  
 
Antiterminator cascade based on double riboswitch 
Synthetic translational to transcriptional control by double riboswitch 
cascade 
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Figure1.8A Structure and sequence of Theophylline and addA 
riboswitch 
 
 
Theophyllineriboswitch=TAGGGTGATACCAGCATCGTCTTGATGCCCTTGGCAGCACCCCGCTG
CAAGACAACAAATG= ΔG = -17.30 kcal/mol 
addAriboswitch=TCAACGCTTCATATAATCCTAATGATATGGTTTGGGAGTTTCTACCAAGAGC
CTTAAACTCTTGATTATGAAGTCTGTCGCTTTATCCGAAATTTTATAAAGAGAAGACTATG =ΔG = 
-21.90 kcal/mol 
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Figure1.18 Design & results of theophylline and addA based 
antiterminator switch 
 
 
 
 
 
 
Figure1.19 Design & results of addA and of theophylline based 
antiterminator switch 
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Figure1.20 design and results of Arkin’s terminator system 
 
 
Conclusion. As our experimental results, we conclude that the stimulating 
effect of a ribosome on transcription elongation occurs predominantly as a 
result of its anti-backtracking mechanism. Also, strong termination hairpins 
do not pause RNAP. Instead, it is a poly-T stretch of the terminator that 
induces backtracking type pauses at the site of termination. They also say 
that hairpins do not affect the rate of elongation.    
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Materials and methods 
 
Common materials and methods 
RNA sequence design. We applied a Monte Carlo Simulated Annealing 
optimization algorithm to design cascades of regulatory RNAs to finally 
control gene expression. The system was composed of three different RNA 
species: two small RNAs (sRNAs) and one 5’ untranslated region (UTR). To 
implement this algorithm, we constructed a physicochemical model based on 
free energies and RNA structures, which involved the energies of activation 
and hybridization corresponding to the interaction between the two sRNAs 
and the energies of activation and hybridization corresponding to the 
interaction between the sRNA complex and the 5’ UTR (see more details in 
Supplementary Information). The model also accounted for the degree of 
repression and exposure of the RBS within the 5’ UTR intramolecular and 
intermolecular structures. Rounds of random mutations were applied and 
selected with the energy-based objective function (figure 3.4). For that, we 
extended a previously reported algorithm for RNA design. We used the 
Vienna RNA package for energy and structure calculation. The sequences of 
riboregulators engineered in this work, as well as their cognate 5’ UTRs. 
 
Plasmid construction 
The plasmids were constructed with standard cloning methods (Sambrook 
and Russel, 2000). For ease of cloning, EcoRI and SpeI sites, allowing Bio 
Brick compatibility, flanked each system. The sRNA systems (sRNA – in 
reverse orientation controlled by Inducible promoter PLlacO1, fused – to the 
5' UTR with ATG and then terminator and reporter protein (GFP) of sTB1002, 
were synthesized (Integrated DNA technologies, USA). The synthesized 
DNA was used for spinning to assure all DNA in bottom. The total DNA 
dissolved in 20 µL in MQ water (DNAase and RNAase free) vortexed then 
incubated at 500C for 5 minutes. 
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Restriction digestion of plasmid and insert 
Type II restriction endonucleases were used to digest double-stranded DNA. 
The 10µL dissolved DNA was used for digestion with EcoRI and SpeI (fast 
digest enzyme from Thermo fisher). 
 
 Insert DNA  10µl 
10X reaction buffer   2µl 
Fast digest EcoR1    2µl 
Fast digest SpeI    2µl 
Water 2µl 
Total 20µl 
 
Total reaction volume is 20µl and incubate 370C for 35 minutes.  
Purification of digested DNA 
We have used QIAGEN PCR purification kit for purification of insert for 
further processing. We have followed the manufacturer instructions.  
 
Agarose gel electrophoresis 
Agarose gel electrophoresis is used to separate DNA fragments on the basis 
of their size. The larger DNA will be migrated slowly and smaller migrated 
faster. The length of DNA fragments compares with marker and isolated the 
desire DNA fragments. The 1% (w/v) agarose dissolve in 1X TAE buffer were 
used and melted. We added 0.5µg/ml ethidium bromide or gel red (10000X 
dilution) and casted in casting tray. The polymerized agarose gel was placed 
in gel running tank in 1X TAE buffer. The digested plasmid was loaded in the 
gel along with marker and control. The gel was run nearly 85V and cut the 
gel in blue light trans-illuminator. 
 
DNA recovery from agarose gel 
The vector DNA (pSTC1) fragment and insert were cut out with razor blade 
under blue light transilluminator. The gel slice dissolved in 500 µl QG buffer 
(3X volume of gel) incubated at 500C for 10 minutes. The dissolved gel 
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transferred in 2 ml Qiagen gel purification column. The column was 
centrifuged at 13000rpm for 1minute.  Discard the flow-through and place the 
column back in the same tube. The add 750µl PE wash buffer to the column 
and spin for 1-minute same speed. Discard flow-through and placed the 
column back the same tube. The centrifuge the column one additional time to 
assure to remove residual ethanol and wash buffer were performed. The pre-
incubated (450C) 35 µl elution buffer adds in column and incubated 420C for 
2 minutes. Centrifuged for 90 second at 13000 rpm. We have measured the 
concentration of insert and vector using the Nano-drop and ligated as below. 
 
Dephosphorization of linearized Vector DNA 
In order to prevent self-ligation of vector DNA, we have used 
dephosphorization of vector with calf intestine alkaline phosphatase (CIP) 
enzyme. The alkaline phosphatase catalyses the hydrolysis of 5’phosphate 
from 5’ end and 3’ phosphate groups from DNA.  
Dephosphorization reaction 
Plasmid vector   33µl 
10X reaction buffer for AP used in reaction 4µl   
Fast AP Alkaline phosphatase  1µl 
Water (Nuclease free) 2µl 
Total  40µl 
 After adding all mix gently, we incubated the reaction mixture at 370C for 25 
minutes. The reaction was stopped by heat inactivation 750 C for 5 minutes.  
Ligation of plasmid vector 
Plasmid vector having either sticky ends, blunt ends or circularization of 
vector can be ligated using the T4 DNA ligase.  
 
 
Plasmid vector  5.50µl (10- 100 ng) 
Insert  2.5 µl (3:1 molar ratio with vector 
10X ligation mixture    2µl (Thermo Fisher)   
Fast T4 DNA ligase            1µl (Thermo Fisher)  
Water  9 µl 
Total  20µl 
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The total reaction volume is 20µl and incubate at 220C for 35 minutes in 
PCR. 
 
Heat shock Transformation of ligated vector in E. coli 
We have used E. coli TOP10 for routine cloning experiments. The ligated 5µl 
final vector mixed into 50µl thaw chemical E. coli competent cells that were 
incubated for 30 minutes on ice.  Subsequently, we gave heat shock 420 C 
for 90 seconds. Immediately placed the cells on ice for 10 minutes and 
added 900 µl LB media. The 100µl-200µl culture were taken and spread on 
LB agar with appropriate antibiotics and kept for overnight (16 to 20h) at 370 
C. 
Primer ligation method to construct control plasmid 
All Control plasmids such as spacer plasmid, ATG knockout, synthetic 
terminator plasmid, leader less plasmid controls were constructed using 
oligos ligation method. We have ordered forward and reverse primers with 
specific restriction site (AvrII and BamH1) and BamH1 and Spe1. The 
forward and reverse primers were phosphorylated in a solution (NEB, and 
Thermos fisher kit and protocol). 
The plasmid vector was also digested with same restriction enzyme, gel 
purify and dephosphorylated. Spacer and terminator were ligated with 
digested and dephosphorylated plasmid backbone. Plasmid backbone of ≈ 
50ng and 1µl of anneal primer with 0.1µm cone with 1µl of T4 DNA ligase 
(Thermo fisher) and 1µl T4 DNA ligase buffer at 220 C for 45 minutes. The 
ligated vector was transformed in 50µl Top10 competent cells thawed on ice. 
The transformed cells were spread on LB/agar that contains kanamycin 
(50µg\ml).  The plate was incubated 37 0C. The single colony was picked 
from plate and screen by colony PCR for further verification (VF2 5-
tgccacctgacgtctaagaa-3 and VR  5-ttcttagacgtcaggtggca-3. The positive PCR 
colonies were screened and confirmed by sequencing.  
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PCR based site directed mutagenesis to construct control 
 Site directed mutagenesis is one of the most important modern biology 
techniques to introduce mutation at specific site of DNA. We have 
constructed some control plasmids (ATG knock out, RBS partially knock out, 
and RBS deletion knockout) by PCR based Site-Directed Mutagenesis 
method. We have designed the forward and reverse primer with specific 
mutation / deletion on target gene. The both forward and reverse primers 
amplified vector with high-fidelity DNA polymerase (NEB). The primer 
generated mutation/ deletion in specific nucleotide of gene. The PCR 
reaction treated with Dpn1 enzyme. The Dpn1 is susceptible to parental 
vector DNA. It digested only parental DNA because parental E. coli is dam 
methylated and it digest the parental vector. 
 
Golden gate cloning  
Golden gate cloning (Engler et al., 2008) was carried out using 1μL BsaI 
(New England Bio labs, Ipswich, USA), 1 μL T4 Ligase (NEB), 2 μL T4 ligase 
buffer and 100 fmol of each DNA fragment used (PCR product, Gblock, 
plasmid or annealed oligo’s), topped up to 20 μL. Reaction was then cycled 
in a thermocycler. 30 cycles: 37°C, 2 minutes; 16°C, 5 minutes then 10 
minutes, 50°C; 10 minutes, 80°C; 4°, hold. Oligos for goldengate were 
annealed by diluting them to 0.1 μM in EB, heating them to 96°C for 5 
minutes in a heat block, switching it off and letting them cool to room 
temperature. 3μL of golden gate reaction were electroporated. Four standard 
bio brick-compatible golden gate cloning plasmids were built and used for 
generic golden gate cloning.  
Gibson Assembly  
1.5X Gibson assembly master mix was prepared with 320 μL 5X ISO buffer, 
0.64 μL T5 exonuclease, 20 μL Phusion polymerase, 160 μL Taq ligase (all 
enzymes from NEB), and 600 μL H2O and kept at -20°C until use. 5X ISO 
buffer preparation: 3 mL Tris-HCl pH 7.5 (1M); 150 μL MgCl2 (2M); 240 μL 
dNTP mix (25mM each dGTP, dCTP, dATP, dTTP) ; 300 μL DTT (1M) ; 1.5 g 
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PEG-8000; 300 μL NAD (100 mM) and 2 mL H2O. Assembly was carried out 
with 100 fmol of each fragment (5 μL added in 15 μL master-mix) and 
incubated at 50°C for 1 hour. 2 μL of reaction were electroporated.  
Bacterial culture and reagents  
E. coli strain DH5α (Invitrogen) was used for plasmid construction purposes 
as described in the manual. All the characterization experiments were 
performed in E. coli DH5α-Z1 cells (Clontech) or in E. coli K-12 MG1655-Z1 
cells (both lacI+ tetR+) for control over the promoters PLlacO1 and PLtetO1. 
For characterization in a fluorometer (TECAN) or in a flow cytometer, 
plasmids carrying systems coop11, coop1 and coop2 were transformed into 
DH5α-Z1 cells, whilst plasmids carrying systems coop31 and coop32 into 
MG1655-Z1. Moreover, plasmid carrying system trigR2 was transformed into 
MG1655-Z1 cells for characterization in a microfluidic device.  
A single colony were grown in LB medium or in M9 minimal medium, 
prepared with M9 salts (Sigma-Aldrich), glycerol (0.8%, vol/vol) as only 
carbon source, CaCl2 (100 μM), MgSO4 (2 mM), and FeSO4 (100 μM). 
Kanamycin concentration was 50 μg/mL. Cultures were grown overnight at 
37 0C and at 225 rpm from single-colony isolates before being diluted for in 
vivo characterization. One mM IPTG (Thermo Scientific) was used for full 
activation of promoter PLlacO1 when needed, and 100 ng/mL aTc (Sigma-
Aldrich) was used for full activation of promoter PLtetO1. For microfluidic 
cultures, cells were grown in fresh LB and in LB supplemented with 0.05% 
sulforhodamine B (Sigma-Aldrich), and IPTG + aTc (i.e., we used 
sulforhodamine B to monitor the presence of inducers in the chamber).   
Gel assay (RNA-RNA inter-action) 
To perform the in vitro transcription, 3μg of each pUC18-derived plasmid was 
digested with Eco31I and purified with silica- based columns (Zymo). We 
used approximately 1 μg of digested plasmid in the reaction. This was in 20 
μL: 10 μL of plasmid, 2 μL buffer 10x (Roche), 0.4 μL DTT 10 mM, 1 μL 
NTPs 10 mM (Thermo-Scientific), 0.5 μLRibolock (~40 U/μL, Thermo 
Scientific), 1 μL inorganic pyro phosphatase (0.1 U/μL, Thermo Scientific), 1 
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μL T7 RNA polymerase (50 U/μL, Epicentre), and 4.1 μL H2O. We incubated 
the mix for 1 h at 37 oC, and then added 20 μL of loading buffer with 
formamide. The samples were heated at 950 C for 1.5 min, then cooled on 
ice, and then separated by PAGE in a 10% polyacrylamide gel, containing 8 
M urea, TBE (1x), (200 V, 2.5 h). We cut the bands corresponding to the full-
length RNAs for purification. The presence of RNA was confirmed by loading 
a small part of the purified preparations in another polyacrylamide gel.  
For the reaction of RNA-RNA interaction, we used approximately 20 ng of 
RNA for each of the transcripts. The buffer of the reaction was 50 mM Tris-
HCl pH 7.5, 10 mM MgCl2, 20 mM NaCl. The mix (20 μL) was denatured 
(1.5 min at 950 C) and slowly cooled (15 min at room temperature) We then 
added 1.5μL glycerol (87%) and 0.2μL bromophenol blue-xylene cyanol 
(100x) to load the gel (15% polyacrylamide, buffer TAE, 1 mm thick), which 
was run for 2 h at 75 mA at 40 C. The gel was stained first with ethidium 
bromide and then with silver. We used the DNA molecular weight marker XIII 
(50 bp ladder, Roche).  
Fluorescence quantification   
Single colony was inoculated and grown overnight (approximately 16 hours) 
in LB medium with antibiotics (spectinomycine 35ng\μL and kanamycin 
35ng\μL. The overnight cultures were then refreshed by diluting 1:200 in M9 
medium with inducer (none, aTc, IPTG, and aTc+ IPTG) and antibiotics. 
They were grown for additional 2 h to then load 200 μL in each well of the 
plate with three technical and biological replicates (Custom Corning Costar). 
The plate was incubated in an Infinite F500 multi-well fluorimeter (TECAN) at 
37 °C with shaking. It was assayed with an automatic repeating protocol of 
absorbance measurements (600 nm absorbance filter) and fluorescence 
measurements (480/20 nm excitation filter - 530/25 nm emission filter for 
sfGFP) every 15 min. All samples were present in triplicate on the plate.  
Normalized fluorescence was obtained by subtracting the background values 
corresponding to M9 medium (in both fluorescence and absorbance values) 
and then dividing fluorescence by absorbance at OD600 ≈ 0.5. Corrected 
normalized fluorescence was obtained by subtracting the fluorescence of 
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plain cells (auto fluorescence). In systems coop1 and coop11, the cis-
repression is very efficient and then the autofluorescence is even higher than 
the normalized fluorescence of transformed cells (assumed to be 0).  
Single-cell microfluidic analysis  
Preparation of PDS chip 
The design of our microfluidic device was performed in AUTOCAD 
(AUTODESK) and was already applied to study a synthetic genetic oscillator. 
All images were acquired using Zeiss Axio Observer Z1 microscopy (Zeiss). 
The microscope resolution was 0.24 μm with Optovariation 1.6X, resulting 
total magnification 1600X for both bright field and fluorescent images. 
Images were analyzed with MATLAB (MathWorks). Cells were tracked by 
defining a cell-to-cell distance matrix and the cell lineages were 
reconstructed. Finally, the fluorescence level of each cell in each 
fluorescence frame was extracted.  
Flow cytometry analysis  
Single colony was inoculated and grown overnight (approximately 16 hours) 
in LB medium with antibiotics (spectinomycin 35ng\ μL and kanamycin 35ng\ 
μL at 200 rpm. The overnight cultures were then refreshed by diluting 1:200 
in LB medium with inducer (none, aTc, IPTG, and aTc+ IPTG) and 
antibiotics. The refreshed culture was grown 2-3 hour to reach an OD600 of 
0.2-0.4. Afterwards, cells were centrifuge 3000 rpm for 5minuts. The 
supernatant discarded   and pellet was   diluted again in 1 mL PBS. All 
expression data were analyzed using a Becton-Dickinson FACScan flow 
cytometer with 488 nm argon laser for excitation and a 530/30 nm emission 
filter (GFP). Gene expression of each sample was obtained by measuring 
the fluorescence intensity of thousands of cells. Data were analyzed using 
the Cytobank webserver by gating the events using scatter ranges, and then 
fluorescence histograms (subtracting auto fluorescence) plotted with 
MATLAB. 
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CHAPTER 2 
 
Engineering single component riboswitches 
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2.1 Abstract 
The coding sequence of transcripts could theoretically encode a different 
protein in each reading frame and some viruses use this mechanism. Non-
coding sequences could still theoretically encode a different RNA molecule in 
each sense of transcription, but it has not been seen in nature aside from in 
the antisense. We hypothesized that it should be possible to engineer a 
synthetic sequence where it would produce a different riboregulator when 
transcribed in each sense. For this, we considered the sequence of a known 
riboregulator and created a 5' untranslated region (5’ UTR) sequence that 
would interact with the molecule corresponding to the reverse-complement of 
the riboregulator. 
Using computational design, we engineered a cis-repressed 5’ UTR that can 
be activated by this new regulator. As a result, both sequences can 
independently activate the translation of their cognate targets. As expected, 
the two riboregulators can also silence one another by antisense interaction. 
We show that it is possible to engineer regulatory elements that can regulate 
different genes depending on the direction of transcription, and that they can 
be interfaced with other circuits used in synthetic biology.  
2. 2 Introduction 
Four combinatorial bases offer the possibility of encoding vast information, 
and even the same sequence can provide, in some cases, multiple functions 
(Johnson and Chisholm 2004). The question we asked was whether a single 
piece of DNA of a given size could encode multiple different functional 
elements for the cell (Kozak 1986). In theory, as the same DNA sequence 
could be transcribed in two ways depending on the localization of the 
promoter, two anti-parallel RNA molecules could be synthesized.  
RNA is a key regulatory molecule as it regulates major cellular reactions 
such as DNA replication, transcription, and translation. There is a growing 
interest for using non-coding RNAs rather than proteins for a number of 
reasons. There are easy tools available to predict secondary structure 
(predictability of folding), and calculation of free energy (DG), (Rodrigo et al., 
2013). The ambisense riboregulatory system would be the new way of 
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synthetic gene regulation in E. coli. This could allow the programmable 
regulation of a gene, depending on the direction of transcription.  This work 
focused on bacterial riboregulators (trans-activating riboswitch) which are 
small RNAs (sRNAs) able to induce a conformational change in a specific 
cis-repressed 5’ untranslated region (5’ UTR) of an mRNA (messenger RNA) 
to modulate gene expression. The 5’ UTR contains a functionally repressed 
ribosome-binding site (RBS). When the sRNA signal binds to the cis-
repressed mRNA, the RBS is uncovered into a fully functional motif and the 
riboswitch gets activated. 
Previously our lab has engineered a small RNA riboregulator (Rodrigo et.al 
2012), sRNARAJ11, that performs a multiplication of the input signals: 
activating gene expression only when all inputs are high. A PLtetO1 
promoter controlled the sRNA RAJ11 which interacted with a cognate 5’ UTR 
containing cis-repressed RBS to initiate the translation of a reporter protein 
(GFP) (Rodrigo et al. 2012). The engineering of an ambisense riboregulator 
often requires the layering of multiple genetic circuits, thus necessitating 
substantial efforts in circuit construction and tuning. Here we have taken 
advantage of our computational de novo design of riboregulators to develop 
two riboregulators that interact with each other through the base pairing 
between the two complementary sequences (Figure 2.1) 
 
2.3 Design and results  
 
2. 3.1 Design of ambisense riboregulator 
Computational sequence design 
The sequence of the RAJ11 sRNA was used as a template. The sequence of 
the antiRAJ11 sRNA was obtained as the negative-sense strand (reverse 
complement) of the RAJ11 sRNA (excluding the transcription terminator). We 
used our original sequence; the RAJ11 sRNA had the B0015 terminator, and 
the antiRAJ11 sRNA the T500 terminator. In order to design the sequence of 
the 5' UTR regulated by the antiRAJ11 sRNA, we used the web-based 
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software Ribomaker (collaboration with Dr. Guillermo Rodrigo, ICPM Spain) 
to automatically design regulatory RNAs that exploit conformational changes 
to control gene expression. It uses a Monte Carlo simulated annealing 
optimization algorithm and the Vienna RNA package to calculate secondary 
structures of different species in the system. Here, the system comprised 
three RNA molecules: the small RNA (sRNA), the messenger RNA (mRNA, 
with the 5' UTR), and the interacting complex. To implement this algorithm, 
we constructed a physicochemical model based on free energies and RNA 
structures that included the energies of activation and hybridization 
corresponding to the interaction between the antiRAJ11 sRNA and its 
cognate 5' UTR. The model also accounted for the degree of repression and 
release of the ribosomal binding site (RBS) within the 5' UTR intramolecular 
and intermolecular structures. Successive rounds of random mutations over 
the 5' UTR sequence were applied and selected with an energy-based 
objective function (Fig. S1). Designed sequences are shown in Fig. S2. 
 Ribomaker was run several times to design the 5' UTR responding to 
the antiRAJ11 sRNA. The heuristic algorithm performs multiple cycles of 
random mutations and selection, and each run produces a different 
sequence. The objective function accounts for on one side, the cis-
repression of the 5' UTR, and on the other, the interaction ability with the 
sRNA. Ribomaker outputs the values of effective free energies (to be 
minimized) corresponding to all partial objectives; and the global objective 
function is a sum of these free energies. From all sequences designed, we 
selected the one with the minimal value of objective function. 
 
To engineer an ambisense riboregulator, we have designed a DNA 
sequence that produces transcripts that are not translated but are able to 
perform function in the cell by activating gene (i.e., regulatory RNAs). These 
transcripts can encode two different target genes depend on the direction of 
the transcript. In our de novo design in E. coli, of the two small RNA 
transcripts one is the reverse complement of the other. We used in-silico 
evolution methods to design our sequence of a new riboregulator 
(antiRAJ11). 
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By using computational design, we have engineered a new riboregulator 
antiRAJ11 (sRNA is the reverse complement of sRNARAJ11 but has the 
same transcriptional terminator) containing an sRNA antiRAJ11 controlled by 
the PLtetO1 promoter which can bind to cis-repressed 5’ UTR mRNA and 
hence lead to the exposure of the RBS of the targeted mRNA and translation 
of the reporter protein Figure 2.2. The sRNARAJ11 and sRNAantiRAJ11 are 
two complementary sequences that can hybridize with each other when co-
expressed in cells (Rodrigo et al. 2016). This leads to the mutual repression 
of the two riboregulators and hence inhibition of their abilities to activate 
downstream translation of their corresponding targets mRNA figure 2.2. To 
implement this firstly, we constructed and characterized each of the two 
riboregulators in two different vectors to demonstrate their ability to activate 
the translation of their target mRNA. Both riboregulators (sRNA) were under 
control of the promoter PLtetO1 (Lutz & Bujard 1997), while the cis-
repressed mRNA was under control of the promoter PLlacO1 (Lutz & Bujard 
1997). The binding to the 5’ UTR of the target mRNA was initiated by the 
seeding site in the 5’ terminal of the riboregulators and hence opening the 
cis-repressed RBSs in the 5’ UTR, leading to the binding of the ribosome on 
the RBS and the translation of the reporter protein (GFP). The two constructs 
were transformed into MG1655 Z1 (expressing lacIQ and TetR (Lutz & 
Bujard 1997) repressors in genome) and the activation of GFP was 
characterized using a fluorescence plate reader Figure 2.2.  The two 
riboregulators activate their target mRNAs, as shown in the results. 
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Figure 2.2 Design and results of RAJ11 and antiRAJ11 
Figure 2.2 Design and characterization of the two riboregulators RAJ11 and antiRAJ11. As 
shown in the map, PLlacO1 promoters’ control both riboregulating small RNAs are controlled 
by PLtetO1 promoter and mRNA expression. The GFP is downstream of the 5’ UTR. The 
GFP-mut3 in case of the RAJ11 system and superfoder GFP with degradation tag in the 
antiRAJ11 system.  Both plasmids were transformed separately into MG1655 Z1 and 
characterized under all possible inducer combinations (none, aTc, IPTG and aTc+IPTG). 
 
Figure 2.2 is comprised of 2 sections. The upper half shows the design of the 
riboregulator pRAJ11, the sRNARAJ11 activates the target cis-repressed 5’ 
UTR mRNA-GFP (Rodrigo et. al, 2012). The Tecan (fluorometer) 
characterization results of GFP in four conditions (none, 100ng/mL aTc, 1mM 
IPTG and aTc+ IPTG) in MG1655Z1 E. coli cells and secondary structure 
mRNA. The lower figure shows the design of the antisense riboregulator 
(antiRAJ11) and characterization results in all four conditions and secondary 
structure of mRNA.  
 
2.2.2 Design of a compact ambisense riboregulator 
The characterization results of the RAJ11 (Rodrigo et al. 2012) and 
antiRAJ11 riboregulator (Rodrigo et.al 2016) have shown the successful 
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activation of the  cis-repressed mRNAs. After these experimental results, we 
have designed a compact ambisense riboregulator into a single plasmid. As 
shown in Figure 2.3A, small RNA RAJ11 was controlled by a promoter 
PLlacO1 in the forward orientation and is controlled by the promoter PLtetO1 
in the reverse orientation that will drive transcription of sRNAantiRAJ11 
(complementary to RAJ11). With this design we can transcribe two 
complementary small RNAs on the same DNA template, depending on 
orientation of the promoter and polarity of the DNA template. In this work, we 
focused on DNA sequences that can produce two small RNA transcripts that 
are not translated but are able to activate two cis-repressed mRNAs 
independently. In this design I have integrated two cistronically fused cis-
repressed 5’ UTR-mRNA (RAJ11 and antiRAJ11) to the sfGFP-LAA. This 
design principally should be able to express sRNA-RAJ11 on induction by 
IPTG and activate cis-repressed 5’ UTR to express the reporter protein 
sfGFP-LAA. The system can also express sRNA-antiRAJ11 on induction by 
aTc and activate, cis-repressed 5’ UTR antiRAJ11 GFP. The co-expression 
of both riboregulators (combination induction of aTc and IPTG) would lead to 
hybridization between the two riboregulators as mentioned before, thus 
returning 0 output of GFP. This system output resembles the electronic 
circuit XOR gate truth table. 
We have characterized the ambisense riboregulator in the E. coli strain 
MG1655Z1 and DH5alpha Z1 (lacIR+, tetR+ and spectR) strains. The 
fluorescence of the reporter GFP was measured in plate reader upon 
different treatment (none, aTc, IPTG and aTc+IPTG) as indicated in Figure 
2.3D. As shown in the results, IPTG treatment activated the expression of 
the GFP as indicated by the increase of the fluorescence. However, no 
activation was found in the aTc treatment, nor inhibition upon combination of 
aTc and IPTG.  
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Figure 2.3 Design and results of compact abmisense riboregulator 
Figure 2.3 (A) Design of compact ambisense riboregulator. Two promoters PLlacO1 and 
PLtetO1 depending on its polarity regulate the sRNARAJ11. The constitutive promoter 
BBa_J23119 controls both 5’ UTRs (binding sites for RAJ11 and antiRAJ11) placed 
upstream of the superfolder GFP. The plasmid transformed MG1655Z1 was characterized 
with all four conditions (0, aTc, IPTG and aTc+ IPTG). The promoter PLlacO1 controls the 
expression of riboregulator sRNARAJ11, while PLtetO1 controls the expression of 
riboregulator sRNA-antiRAJ11 (reverse complemental to sRNARAJ11), and the GFP mRNA 
was under control of the constitutive promoter BBa_J23119.   
(B). The induction of riboregulator with IPTG; PLlacO1 promoter will activate and transcribe 
sRNARAJ11, this will activate cis-repression mRNA-RBS of RAJ11 and GFP will be 
expressed.  
(C). Induction of riboregulator with aTc, PLtetO1 promoter will activate and transcribe 
sRNAantiRAJ11. This will activate cis-repression mRNA-RBS of antiRAJ11 and exposed 
RBS leading to expression of GFP.  
(D). Induction of riboregulator with inducer aTc and IPTG would express sRNARAJ11 and 
sRNAantiRAJ11, respectively. Both sRNAs (RAJ11 and antiRAJ11) are complementary, so 
they hybridize and no GFP is produced.  
 
The construction (ambisense riboregulator plasmid) shown in figure 2.3A 
was transformed into MG1655Z1 cells and the fluorescence was 
characterized with plate reader (Tecan 500) under different treatment of 
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inducers as indicated in the Figure 2.3E.  
The failure of the output 0 in the combination of the two small RNAs could be 
due these possibilities: 
1. Promoter Competition: Face-to-face promoters controlling the 
reverse complementary riboregulators could lead to competition for 
RNA polymerase between the two promoters. In our case, it seems 
that PLlacO1 promoter dominates the expression, leading to no 
transcription of the antiRAJ11 which is under control of PLtetO1 
(Brophy & Voigt 2016). 
2. Occlusion: RNAP binds to the strong promoter, in this case PLlacO1, 
and RNAP elongates over the other promoter (PLtetO1) during 
transcription and transiently blocks the other (Brophy & Voigt 2016).  
3. Collision: Two actively transcribing RNAPs collide and the stronger 
wins.  
4. The fused 5’ UTR cis-regulatory regions in our case can interfere each 
other. The riboregulator antiRAJ11, ever if it was expressed from the 
PLtetO1 promoter, could not bind to the 5’ UTR (antiRAJ11) if the first 
5’ UTR (RAJ11) was not opened. This may explain why there is no 
activation of fluorescence upon treatment of aTc inducer.  
5. The two-different small RNA have different stabilities. 
6. The PLacO1 promoter is leaky and it always express sRNARAJ11 
and inhibits sRNAantiRAJ11. 
To further understand my design and in the end successfully construct an 
ambisense riboregulator, I have co-transformed this system together with 
another high copy number plasmid expressing the antiRAJ11 small RNA 
riboregulator under control of PLtetO1 (Figure 2.4).  We have used the same 
strain MG1655Z1 to characterize the fluorescence of the GFP upon 
treatment of aTc or IPTG, or both. As shown in Figure 2.4, co-expression of 
another plasmid, which could normally express the riboregulator 
sRNAantiRAJ11 upon treatment of aTc, has led to the return 0 in the 
combination of the aTc and IPTG. In other words, sRNAantiRAJ11 could 
inhibit the sRNARAJ11 to activate the 5’ UTR cis-repressed GFP expression. 
This result indicated that our complementary riboregulators could 
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successfully generate an ambisense riboregulator gate in a new manner that 
does not exist so far.  
 
Figure 2.4 Results of co-transformed sRNA 
 
Figure 2.4. A Co-transformation of another plasmid expressing riboregulator sRNA 
antiRAJ11 with the previous design; (b) characterization of the fluorescence of the GFP. 
Although there was still no activation of the fluorescence upon treatment with aTc, the 
combination of aTc and IPTG could lead to inhibition of the fluorescence indicating the 
functional RNA-based XOR gate (0 output with two inputs). The Different concentration of 
IPTG values demonstrated that there were no significant changes in the inhibition of the 
GFP. 
We have also treated the cells co-transformed with the two plasmids with 
different concentration of IPTG. However, we didn’t see any significant 
change in the 0 output upon treatment of both inducers. These results 
underscored that our previous design was problematic. On the one hand, the 
face-to-face promoters could not work properly since there was no 
transcription of sRNA antiRAJ11 upon treatment of aTc. On the other hand, 
the cistronically fused 5’ UTR was non-functional for the second 5’ UTR.  
These two important factors led to the hypothesis that: 
1. Two promoters could interfere if they are too close two each other. 
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2. Two cistronically fused RBSs could interfere each other and may be 
making a pseudoknot. 
 
2.2.3 Design of an ambisense riboregulator using ribozymes 
My above design (compact ambisence riboregulator) did not work properly, 
so I designed an ambisense riboregulator based on ribozyme. 
Ribozymes (ribonucleic acid enzymes) are RNA molecules that are capable 
of catalyzing specific biochemical reactions, similar to the action of 
protein enzymes. Many ribozymes cleave RNAs in trans, such as RNase P 
which processes transfer RNAs (tRNAs), or self-cleave, such as the 
Hammerhead or Hepatitis D virus (HDV) ribozymes (Serganov and Patel, 
2007). We used hammerhead ribozyme, which is a small catalytic RNA 
motif made up of three base-paired stems and a core of highly conserved, 
non-complementary nucleotides essential for catalysis. Similarly, to what 
occurs in some RNA organisms such as viroids, we can use ribozymes 
(Markus Wieland and Jörg S. Hartig 2008), (Yangbin Gao and Yunde Zhao 
2014)in each sense (or polarity, as it is called in viruses) that will cleave the 
transcript at appropriate positions to remove undesired sequences. I took 
advantage of the self-cleavage activity of ribozyme, hypothesizing the 
following: that PLlacO1 promoter controlled HHR1 ribozyme and terminator 
sequence and after induction of IPTG the system transcribed small RNA-
RAJ11 and HHR1 ribozyme. The ribozyme HHR1 would then self-cleave and 
release small RNA. This small RNA would activate 5’ UTR RAJ11and 
express RFP. The same mechanism would occur for opposite polarity but in 
the reverse orientation using the PLteO1 promoter, the antisense strand of 
sRNARAJ11 (antiRAJ11) and HHR2 ribozyme and terminator. After induction 
of aTc, the system would transcribe in reverse orientation with antiRAJ11 
and HHR2. The antiRAJ11-HHR2 complex would then cleave and release 
sRNAantiRAJ11. This antiRAJ11 would trans-activate 5’ UTR antiRAJ11 and 
express GFP. 
Each sense transcribes two different sRNAs targeting two different 5’ UTRs 
where they activate their respective genes. The Raj11sRNA, transcribed by 
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the PLtetO12 promoter in the forward direction, binds to the CisRaj11 5’ UTR 
to activate the mRFP reporter protein. The antiRaj11sRNA (the reverse 
complementary of Raj11sRNA), transcribed by the PLlacO1 promoter in the 
reverse direction, binds to the cis_antiRaj11 5’ UTR to activate the sfGFP. 
Our goal was to transcribe two small RNA transcripts with the same DNA 
template depending on polarity of DNA sequence and has these transcripts 
activate two separate genes independently. The first compact ambisense 
riboregulator design we made was unable to transcribe two sRNAs from the 
same DNA template. That is why we designed a new ribozyme based 
ambisense riboregulator as shown in the Figure 2.5A  
1. In this design, the PLlacO1 promoter controls HHR1 ribozyme 
sRNARAJ11and transcriptional terminator. The inducer IPTG will 
activate the promoter PLlacO1 and this will trigger the transcription of 
ribozyme-sRNARAJ11. The ribozyme will self-cleave and free the 
sRNARAJ11. This sRNARAJ11 will hybridize to 5’ UTR-RAJ11 and 
activate the expression of the RFP reporter protein.  
2. The aTc inducer will also activate the promoter PLtetO1 in the reverse 
direction and transcribe sRNA antiRAJ11ribozyme2. The ribozyme will 
self-cleave and free the sRNAantiRAJ11. This sRNAantiRAJ11 would 
hybridize antiRAJ11 5’ UTR and open the RBS and the GFP will be 
expressed. 
3. Upon induction by both inducers IPTG and aTc, IPTG activates 
PLlacO1 promoter and transcribes sRNARAJ11 and aTc will activate 
the PLteto1 Promoter in reverse direction and transcribe 
sRNAantiRAJ11. Both sRNAs are reverse complements of each other 
and would hybridize and repress each other. Ultimately there would 
be no activation of either cis-repressed 5’ UTR and so no expression 
of the reporter protein. 
 
We characterized our ribozyme based ambisense system in four different 
conditions (none, aTc, IPTG, aTc+IPTG). As shown in the figure 2.5B, no 
activation was seen in any conditions. Possible reasons for failure are: 
1. The terminator could be working bidirectionally so it may terminate in 
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reverse direction as well, such that no sRNA is transcribed. 
2. The ribozyme may be unable to cleave, such that sRNA is not free to 
activate cis-repressd 5’ UTR, ultimately leading to no expression of the 
reporter protein. 
3. The promoter is too close so that they interfere each other and ultimately 
no expression of reporter protein occurs. 
 
Figure 2.5 Design and results of ribozyme based on ambisense riboregulator 
Figure 5.A Design of the ribozyme-based ambisense riboregulator. The promoter PLlacO1 
controls ribozyme HHR1 sRNARAJ11 with reverse direction ribozyme and terminator (Tt1). 
The IPTG induction will activate PLlacO1 promoter and sRNA RAJ11 will transcribe and 
cleave and release sRNARAJ11. This sRNA would bind cis-repressed 5’ UTR-RAJ11 and 
will activate reporter protein RFP. The inverse promoter PLtetO1 controls expression of 
sRNAantiRAJ11 ribozyme HHR2 and its terminator (tim liu term). The aTc induction would 
activate promoter PLtetO1 and transcribe sRNAantiRAJ11. The sRNAantiRAJ11 would bind 
5’ UTR-antiRAJ11 and activate the reporter protein. The induction of aTc and IPTG would 
trigger the expression of both complementary RNAs. They are reverse complement of each 
other and they would hybridize resulting in no expression of reporter protein. 
 
Design of RNA based on orthogonal ambisense riboregulator 
To solve our problem with the activation of PLtetO1 promoter, we have 
designed and synthesized two orthogonal plasmids (pMR01 and pMR02 as 
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shown in the Figure 2.6).  These are orthogonal rioboregulators. This new 
design enabled us to test the orthogonality between the two riboregulators 
and their corresponding 5’ UTR. Meanwhile, it also finally allowed us to 
construct an ambisense riboregulator. 
 
Figure 2.6 Design and results of orthogonal ambisense riboregulator 
 
Figure 2.6. New design of the ambisense orthogonal riboregulator and its characterization.  
Two orthogonal riboregulators were designed and constructed. These 
orthogonal riboregulators were co-transformed in MG1655Z1 strains. The 
inducer IPTG activates PLlacO1 promoter and transcribes sRNARAJ11. This 
sRNARAJ11 activates cis-repress mRNARAJ11 of another plasmid and 
expresses GFP. The induction with aTc would activate promoter PLtetO1 
and transcribe sRNAantiRAJ11, expressing GFP of another plasmid. These 
sRNARAJ11 and sRNAantiRAJ11 are both complementary to each other 
and would hybridiz if co-expressed with induction aTc+ IPTG. 
The characterization results showed: 
1. The induction of the system with inducer aTc triggers the transcription 
of sRNAantiRAJ11. This sRNAantiRAJ11 binds to cross system and 
activates cis-repressed mRNA of antiRAJ11 and GFP is expressed.  
2. The induction of the system with inducer IPTG triggers the 
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transcription of sRNARAJ11. This sRNARAJ11 binds to the cross 
system and activates cis-repressed mRNA and GFP express. The 
figure shows huge expression of GFP. 
3. The induction of the system with both inducers aTc and IPTG triggers 
the transcription of both sRNARAJ11 and sRNAantiRAJ11. According 
to the hypothesis, both sRNA (RAJ11 and antiRAJ11) are reverse 
complementary of each other and so they should hybridize. The 
results in figure show that GFP expression is reduced. 
4. This suggests that both small RNA (sRNARAJ11 and antiRAJ11) are 
transcribed with the induction of inducer IPTG or aTc and are able to 
activate their respective cis-repress mRNA. The induction of the 
system with both inducers (aTc and IPTG) results in the transcription 
of both sRNAs and they are able to hybridize and repress GFP 
expression. 
The two plasmids are of different copy number that they transcribe 
different amounts of sRNA. They cannot mutually hybridize completely 
and therefore the system cannot repress completely. Both the 
systems have autofluorescence and system could not show good 
activation. The E. coli has RNAse III that could degrade some amount 
of sRNA. 
To balance both system sRNA, I tuned the system with different 
concentrations of IPTG and characterized and analyzed the results. 
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Figure 2.7 the characterization of orthogonal ambisense riboregulator at aTc (25ng/ml) and 
IPTG 1mM concentration. The results show activation upon induction with aTc and IPTG 
independently.  
The induction with both inducers (aTc+IPTG) represses the system, but both 
activation and repression are very much reduced. Here we have success at 
some level of engineering an ambisense riboregulator. The system has auto-
fluorescence and PLlacO1 has leakiness so at some level it hybridizes 
sRNAantiRAJ11 such that activation and repression is not significant. 
 
Engineering of minimum alphabet (riboregulator with three 
nucleotides 
The RNA-world hypothesis suggest that’s life is based on RNA, before arrival 
of DNA and protein (Roger and Joyce 1999). The RNA had a role both 
genetic information and catalytic function. Protein have much diversity (20 
a.a) as compared of RNA (4 nucleotide only). We proposed a hypothesis and 
experimentally validated that original genetic material contains fewer 
nucleotides than four different have now. It is possible that three nucleotides 
of RNA are sufficient for maintaining secondary structure and activation. 
Therefore, the engineering of RNA with a minimal alphabet is proposed. 
 
Figure 2.7A RNA switch with three alpha-bate GCU only 
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We engineered new RNA switch that has three nucleotides only. We 
engineered without adenine nucleotide in the sequence. The idea is based, 
on Watson-crick base pairing theory, where Guanine base pair with cytosine 
and it has strongest interaction. Although Guanine will also pair with uracil. 
The base pair between guanine and cytosine is the strongest of the Watson-
Crick base pairs as they form 3 hydrogen bonds. Whereas the guanine and 
uracil wobble pair only have 2 hydrogen bonds, which means they have a 
weaker interaction (Szatylowicz and Sadlej-Sosnowska 2010). Therefore, 
sequences that can only form G-C Watson-Crick pairs and G-U wobble pairs 
should be sufficient to produce complex secondary structures. 
We successfully engineer small RNA that have three nucleotide and this 
small RNA activate cis-repressed mRNA that also has three nucleotides. The 
three nucleotides (GCU) riboregulator bind with cis-repressed mRNA. 
This is possible by In-silco evolution of Guanine beginning with mutating the 
adenine bases of a synthetic RNA into guanines. Mutating adenines into 
guanines was the starting point as guanines are able to interact with 
cytosine, following the Watson-Crick model, as well as being able to form 
wobble pairs with uracil. Therefore, there would be more opportunities for the 
guanine to form a base pair when the sequence is folded into its secondary 
structure compared to if the adenines were initially mutated to a cytosine or 
uracil.  
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Figure2.7B Design & results of GCU (minimal alpha bates) RNA switch 
Study of orthogonality of riboregulator. 
In order to engineer a robust system, we studied orthogonality of different 
small RNAs to each other and the host cell, the orthogonality of cooperative 
riboregulators and additionally the orthogonality of riboregulators that have 
been engineered in our laboratory (Rodrigo et al. 2012). The results explain 
that neither small RNAs have crosstalk between their small RNA and host 
cell.  Additional tested orthogonality of previously engineered riboregulators 
in our lab (Rodrigo et.al. 2012). The all riboregulator tested. I made two 
combinations riboregulator RAJ12 tested with all small RNA (sRNARAJ11, 
sRNARAJ12, sRNARaJ21, sRNA RAJ23 and sRNA31). The 2nd 
combinations were RAJ31 with all small RNA (sRNARAJ11, sRNARAJ12, 
sRNARaJ21, sRNA RAJ23 and sRNA31).  
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Constructing single copy RNA switches in 
E. coli 
2.7.1 Abstract 
Researchers are becoming more interested in the ability to engineer genetic 
circuits. These genetic circuits are engineered in multi copy plasmid. This 
multi copy plasmid is unstable in the cell and increases metabolic burden. 
The multi copy plasmid has different rates of growth which is dependent on 
strain-to-strain. We have engineered our genetic circuits in this plasmid and 
studied the gene regulation at the post-transcriptional level. These plasmids 
have variable copy numbers which can differ between cells. This fluctuation 
in the growth rate causes a hindrance in data analysis and the resulting 
outcomes are not constant between strains. This causes the gene 
expression analysis to be noisier. Hence, there is a need to develop a 
system for making genetic circuits in a single copy that will reduce the 
metabolic burden and variability of data. This could be possible by integration 
of the genetic circuits into the chromosome of the E. coli genome. These 
circuits, once integrated in the chromosome would have minimum metabolic 
burden, consistent results and the circuits would be stable in the 
chromosome without antibiotics. 
In this study, we have integrated in house constructed RNA circuits RAJ11 
(Rodrigo et al. 2012) into the E. coli K12 (MG1655Z1) strain. These RNA 
circuits had studied in multi copy plasmid pSTC1 (Rodrigo et al. 2012) 
pSC101mutated medium high copy plasmid. The integration of large size 
circuits in the E. coli is challenging and limited methods are available: 
1) Lambda based recombineering  
2) Phage derived method  
3) Cas9 based system.  
In the following study we used the Lambda based recombineering method 
based on the Thomas and Khulman 2010 NAR paper. Chromosomal 
integration of DNA is thus critical in synthetic biology, biotechnology, and 
metabolic engineering. 
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2.7.2 Introduction 
Chromosomal engineering allows us to study gene regulation at the single 
copy level in vivo and is therefore an essential application of synthetic 
biology. Previously developed methods include a two-step recombineering 
methodology for the integration of large fragments of DNA into the E. coli 
chromosome (Thomas and Cox et al., 2010; François et al.,2013; Pengfei et 
al., 2015). This integration system includes three plasmids (figure 2.7.1) 
pTKRED plasmid, which carries λ-RED recombineering enzyme control by 
LacI regulated promoter and induced by Isopropyl β-D-1-
thiogalactopyranoside (IPTG). The plasmid also has I-SecI endonuclease 
excision enzyme control by pBAD promoter and induced by arabinose and, 
constitutively expressed Rec-A protein. The endonuclease I-SecI makes 
double stranded breaks in the E. coli chromosome and λ-RED promote 
Recombineering. The second plasmid (pTK/Cs), which carries 1.3kb size 
Landing pad tetracycline resistance gene (tetA) flanking with I-secI restriction 
site. This landing pad was designed to be unique to the E. coli chromosome 
and provide platform for the integration of large fragments of DNA into the 
chromosome. YgcE-YgcE location in chromosome as mentioned by Thomas 
and Cox (Cox and khulman 2010) was used. 
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A third donor plasmid (pTKIP), has multiple cloning site.  We constructed   
our house engineered riboregulator RAJ11 (Rodirgo 2012 et, al.,) in donor 
plasmid pTKIP- RAJ11. This pTKIP-RAJ11 ready to harbors the riboregulator 
and integrated into the chromosome. In RAJ11 we have previously 
developed a small RNA riboregulator based gene expression regulatory 
system in vivo, in which a small trans-RNA hybridizes with the cis-repress 5’ 
UTR of the targeted mRNA to expose the ribosome binding site (RBS) to 
launch the protein translation. In the following study, we have integrated 
small RNA regulatory (RAJ11) system into the chromosome of E. coli to 
study gene regulation at single copy in the chromosomal level. This would 
enable a better understanding of the regulation mechanism and parameters 
of the small RNA based gene circuits. In summary, here we have established 
previously discovered recombineering system, which is a simple technique 
used to integrate large fragments of DNA into any desired location in the 
chromosome.  
2.7.3 Material and method 
2.7.3.1A-Landing pad integration-Competent cell preparation 
Plasmids (pTKRED, pTK/CS and pTKIP) were a kind donation from Thomas 
and Khulman, USA (Department of Molecular Biology, Princeton University, 
Washington Road, Princeton USA). Electro-competent cells of MG1655Z1 (a 
modified strain with E. coli K12, having laciQ and tetR gene in the 
chromosome and spectinomycine antibiotic resistance) were cultured 
following a standard protocol. pTKRED plasmid was transformed in 
MG1655Z1 electro-competent cells and grown in 30°C temperature. The 
plasmid pTKRED is a temperature sensitive plasmid and cannot survive at 
37°C. The transformation of pTKRED was confirmed by PCR since plasmid 
and cells were resistant to the same antibiotic. Electro-competent pTKRED-
transformed cells were developed. The single colony was inoculated in 2 mL 
LB media with spectinomycin antibiotics and overnight grown for nearly 16 
hours at 30°C. The overnight culture was subcultured in 100 mL LB media in 
a 1L conical flask with 100-fold dilution. the culture was supplemented with 
0.5% w/v glucose and 100 mg/ml spectinomycin and 2mM IPTG after 2 
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hours of growth. This enabled production of the Lambda red enzyme which 
increases the efficiency of recombineering. When the optical density (OD) (l 
= 600 nm) of the culture reached 0.5–0.6, the cells were placed on ice and 
washed three times with ice-cold 10% v/v glycerol.  
 
2.7.3.2 Landing pad integration  
Plasmid pTKS/CS was used as a PCR template to amplify landing pad 
fragments using the landing pad regions as standardized priming sites. The 
forward primer was ygcE/ygcF S/CS F, with the following sequence: 
5’-
TCAACAGCGTATAGAGGCGGTTATGTAAAACCACTCATTAGCCTCAAAACTACGGCCCC
AAGGTCCAAACGGTGA-3’ 
The reverse primer was ygcE/ygcF S/CS R, with the following sequence: 
5’-
GATACAAAAAATTAAATTTAATCAAAGTGTTATTTGTATGATTCTTAAATTTGGCTTCAGG
GATGAGGCGCCATC-3’. 
The primers included 50-bp sequence homology for the desired insertion 
location in the chromosome (Thomas and Khulman 2010). NEB Phusion 
polymerase (HF) DNA polymerase PCR conditions were as follows: 98°C  for 
60 seconds, followed by 30 cycles of: 98°C for 35 seconds, 55°C for 45 
seconds and 72°C for 45 seconds. The resulting PCR reactions was 
digested with 1µ DpnI for at least 2 hours at 37°C. The PCR product was run 
on a 1% agarose gel and purified using a Qiaquick spin column. The 100 µ 
plasmid pTKED containing competent cells and 300 ng of purified landing 
pad PCR fragment was electroporated. Additionally, 1µl pTKRED plasmid 
was added for safe site and increasing recombineering. Mechanism of 
integration of large fragment.  
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Mechanism of integration of large fragment.  
Following the electroporation, 1 ml SOC/LB medium was added with 2 mM 
IPTG. After recovery for at least 2 hours, antibiotics were added and the 
cultures were grown at 30°C for 6 hours. After 6 hours of recovery, 500µl of 
the culture was plated on LB agar plates containing 10 mg/ml tetracycline, 
100 mg/ml spectinomycin and 0.5% glucose and grown overnight at 30°C. 
The cells were grown overnight at 30°C so that the pTKRED plasmid did not 
die. The colonies were collected after 24 hours, three colonies were 
inoculated and grown in LB with specific antibiotics at 30°C.  
Following the protocol detailed in the thermo-fisher bacterial genomic DNA 
isolation kit the genomic DNA of E. coli of culture was isolated.  
The overnight 1ml bacterial culture was centrifuged in a 1.5ml micro-
centrifuge for 10 min at 6000 x g. The bacterial cells were re-suspended in 
200μl of TE buffer. 200μl of sample was mixed with 400 μl of lysis solution 
and incubated at 65°C for 5 min. After incubation, 600 μl of chloroform was 
added and gently emulsified by inversion (3-5 times) and the sample was 
centrifuged at 10,000 rpm for 2 min. Precipitation solutions were prepared 
using 80 μl of supplied 10X concentrated precipitation solution mix (provided 
in the kit) and mixing 720 μl of sterile deionized water. The upper aqueous 
phase containing DNA was transferred to a new tube and 800 μl of freshly 
prepared precipitation solution mix was added. The tube was gently mixed at 
room temperature for 1-2 min and centrifuge at 10,000 rpm (~9400 x g) for 2 
min. The supernatant was removed completely and the dissolved DNA pellet 
was resuspended in 100 μl of NaCl solution by gentle vortexing. To the tube, 
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300 μl of cold ethanol was added and the DNA was precipitated (10 min at -
20°C) and spun down at 10,000 rpm (~9400 x g), 3-4 min. The ethanol was 
removed and the pellet was washed once with 70% cold ethanol. The 
precipitated DNA was resuspended in 100 μl of sterile deionized water by 
gentle vortexing. (Thermo-fisher genomic DNA isolation kit (K0512)).  
The genomic DNA was amplified by PCR with specific verification primers. 
These primers were nearly 100 bp outward of insertion site in order to ensure 
the right location of the insertion of the landing pad. The verification primers 
were: 
ygcE/ygcF ver F (Sequence: 5’- CGCTGATGCAGGGAACATAATAAAAAC-3’) 
ygcE/ygcF ver R (Sequence: 5’-CCCCGCGCCAGCGGGGATAAACCA-3’) 
Thermo-fisher dream-taq master mix DNA polymerase was used and the 
PCR conditions were as follows: 95°C for 60 seconds, followed by 30 cycles 
of: 94°C for 35 seconds, 55°C for 45 seconds and 72°C for 90 seconds.  
Three colonies were amplified and one of MG1655Z1 genomic DNA was 
used as a negative control. 10 µl of PCR product was checked on 1% 
agarose. The positive PCR were purified (Qiagen purification kit) and sent for 
sequencing for conformation. 
 
2.7.3.3 Construction of the RNA circuit donor plasmid pTKIP-
RAJ11 
The pTKIP-RAJ11 plasmid was constructed with standard cloning method. 
The pTKIP plasmid was digested with the enzymes EcoR1 and Spe1. The 
sRNA cassette in RAJ11 plasmid also has same restriction site. The 
digested backbone and RNA cassette were both gel purified. The pTKIP 
backbone was given dephosphorization treatment to prevent self-ligation. 
The backbone and RNA cassette were ligated with standard method used 
thermos-fisher kit. The positive clone was confirming by colony PCR and 
sequencing. 
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2.7.3.4 Integration of RNA cassette in bacterial genome 
 
Competent cell preparation of landing pad integrated E. coli 
strain 
Competent cells were prepared which had the landing pad. Landing pad-
integrated clone was grown overnight in the antibiotics spectinomycin   and 
tetracycline. The overnight culture was sub-cultured in 1:100 dilutions and 
supplemented with 0.5% w/v glucose and 100 mg/ml Spectinomycin and 
tetracycline. To the culture, 2mM IPTG was added after 2 hours for the 
synthesis of the lambda red enzyme. Once the OD600 of the culture reached 
0.5 the cells were made electro-competent. I PCR amplified an RNA cassette 
with an additional Landing pad and I-SecI restriction site from pTKIP-RAJ11 
Plasmid. One hundred fifty ng of purified PCR product and 1µl pTKED (for 
safe guard of integration) was transformed in 1ml SOC media with 
supplemented 2mM IPTG (for synthesis of Lambda RED) and 0.2% W/V L-
arabinose. The culture was incubated for 1 hour in a shaking water bath at 
37°C and Spectinomycin was then added to the culture tube which was 
transferred to a 30°C bath. The remaining 500 ml was allowed to recover 
overnight and plated the next day. Potential integrants were picked onto LB 
plates supplemented with 34 mg/ml chloramphenicol to screen against 
colonies which had been transformed with undigested pTKS/CS plasmid. 
The high level of expression from the PlacIQ1 promoter combined with the 
significantly decreased growth rate of cells expressing tetA (24) made it easy 
to distinguish landing pad integrants from higher copy number pTKS/CS 
transformants, and, consequently, all potential integrants passed this screen. 
Chromosomal landing pad integrants cannot grow on low nutrient LB agar 
plates supplemented with fusaric acid (25). Samples were verified by colony 
PCR across the desired insertion junctions and confirmed by sequencing. 
 
2.7.3.5 Insertion of Raj11 in genome 
Plasmid pTKIP has multiple cloning sites, therefore we digested pTKIP and 
Raj11 with EcoR1 and Spe1. Raj11 ligated into the backbone of pTKIP.  The 
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pTKIP plasmid was then transformed into the landing pad in MG1655Z1 
cells. This integration was confirmed by sequencing. 
 
2.7.3.6 Tecan characterization 
Before characterization experiments, cells were grown in LB overnight in 
order to reach the stationary phase. Overnight cells were diluted 200 times 
and induced with ATC and IPTG inducer. When cells reached an OD 
between 0.30 to 0.40 they were diluted 200 times in 200 mL of M9 within 
each well of the plate (Custom Corning Costar 96 well microplate, black 
transparent bottom with lid). The plate was incubated in an Infinite F500 
multi-well fluorometer (TECAN) at 37 °C with shaking (orbital mode, 
frequency of 33 rpm, 2 mm of amplitude) and assayed with an automatically 
repeating protocol of absorbance measurements (600 nm absorbance filter) 
and fluorescence measurements (480/20 nm excitation filter - 530/25 nm 
emission filter for GFP. The ime between repeated measurements was 15 
minutes. All samples were present in triplicate on the plate. Each 
measurement was repeated 2-3 times on independent days to verify 
reproducibility in the results. All data were analyzed by MATLAB. 
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Landing Pad integration 
 
Screening of positive landing pad insert 
The figure 2.7.5 showing position of ygcE-ygcE in chromosome of E. coli. 
The Gel showing the PCR confirmation.  Lane1 – 100 bp Marker. Lane- 
2,3&4 three clone showing positive band. I used ygcE-ver FW and ygcE ver 
RW prime nearly outside of ygcE origin in chromosomal showing right 
position of integration.Lane 5. Negative control (MG1655Z1 cells without 
landing pad).  
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Integration of Raj11 in the E. coli chromosome  
 
 
 
 
 
 
 2.7.7Results and discussion. The figure 2.7.7 showing fluorimeter 
characterization results in four conditions (none, aTc, IPTG and aTc+IPTG). 
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The activation of GFP is not shown. The conclusion is that RNA has a very 
sort life period. The single copy RNA is degraded before reaching to the 
target mRNA.  
The characterization data of these results, I collaborate this data with Dr. 
Rodrigo (ICMP, Valencia Spain.)  and he develop a biophysical model and 
we publish in Biophysical journal 2015.  
 
Adapted from JMB paper. 
Functionalization of antisense RNA.  
Antisense RNA has a potential role in posttranscriptional regulation of gene. 
The antisense oligo was used as to control growth of bacteria. The antisense 
technology (RNA interference) is most common to regulate gene expression 
in eukaryotes. In our system antisense regulation depends on polarity of 
DNA sequence. Our system able to transcribe two sRNA from same DNA 
template depends on polarity of of DNA template and direction of promoter. 
We engineer a system that working as an antisense and we validate in In-
vivo as well In-vitro. To this end, we focused on DNA sequences that 
produce transcripts that are not translated but are able to perform a function 
in the cell (i.e., regulatory RNAs), (Storz et al., 2009). In particular, we 
considered a scenario of an antisense small RNA as pre-existing gene, a 
transcript able to sequester a functional sRNA in trans. This antisense 
regulatory mechanism has already been described in prokaryotes (Georg 
and Hess 2011) and eukaryotes (Ebert et al., 2007) and this work will show 
that an antisense small RNA may acquire an additional ability to directly 
control gene expression. We present a synthetic case in Escherichia coli, 
where the two-transcribed small RNAs, one the reverse complement of the 
other, can independently activate gene expression and repress each other 
when both are present.  
The sRNA antiRAJ11 was designed as the reverse complement of the sRNA 
RAJ11 (without accounting for transcription terminators). Then, using 
RiboMaker (Rodirgo and Jaramillo 2014), a computational approach 
following certain energetic and structural criteria we designed a 5' UTR 
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sequence that is able to cis-repress the RBS (and block translation) and to 
be trans-activated by the new riboregulator antiRAJ11. The RNA sequences 
are shown in table1. The heuristic algorithm performs multiple cycles of 
random mutations and selection, and each run produces a different 
sequence. Hence, we ran the RiboMaker software multiple times and 
selected the best sequence according to the objective function. Note that it is 
not possible to construct the 5' UTR antiRAJ11 as the reverse complement of 
the 5' UTR RAJ11 because it would lack a suitable RBS sequence. 
Moreover, riboregulatory systems require a precise secondary structure, 
followed by toehold formation, which is not maintained after a reverse 
complementation operation due to the existence of GU wobble pairs. 
We used inducible promoters (Lutz and Bujard 1997) to dynamically control 
the expression of our system with isopropyl-b-D-1-thiogalactopyranoside 
(IPTG) and anhydrotetracycline (aTc). The design of the full expression 
cassette (including the promoters and terminators of the sRNA and mRNA) 
was performed according to the protocol previously published (Rostain et al., 
2015) The characterization of the system in vivo at the population level 
revealed a high dynamic range Figure. 2.2 antiraj11 results. We then tested 
the ability of the riboregulator RAJ11 to inhibit the action of the riboregulator 
antiRAJ11, as they hybridize perfectly with each other. When co-expressing 
both riboregulators, we observed a remarkable decrease in GFP expression 
Figure. 2.8. We also tested the ability of the riboregulator antiRAJ11 to inhibit 
the action of the riboregulator RAJ11, obtaining a reduction in GFP 
expression but less substantial than in the previous case Figure. 2.9.  
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Using in vitro translation, where the complementary DNAs (cDNAs) 
corresponding to the RNA species were first transcribed in vitro, we also 
proved the dynamic behavior of the new system antiRAJ11, and that the 
sRNA RAJ11 can inhibit it Figure. 2.10. Consequently, it turns out that the 
appropriate activation of the target genes (genes regulated either by the 
riboregulators RAJ11 or antiRAJ11) could require non-simultaneous 
expression regimes of the riboregulators.  
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(Note figure 2.10 adapted from Guillermo and Prakash JMB 2016) 
In addition, we studied to what extent one riboregulator can affect the targets 
of the other (i.e., if they are orthogonal). For this, we measured the change in 
GFP expression from the mRNA controlled by the non-cognate 5' UTR in 
presence or absence of the sRNA (i.e., crossed systems). We found that the 
riboregulator antiRAJ11 has no significant impact on the GFP controlled by 
the 5' UTR RAJ11 and the same applies for the riboregulator RAJ11 on the 
GFP controlled by the 5' UTR antiRAJ11. We also found that in both cases 
the 5' UTRs are very efficient at repressing translation. Simulations with an 
RNA physicochemical model (Hofacker et al.,) revealed no significant free 
energy of hybridization between the non-cognate sRNAs and mRNAs, 
supporting the orthogonal behavior. Finally, and to get mechanistic insights, 
we performed a native polyacrylamide gel electrophoresis (PAGE; details in 
material and methods), where the cDNAs were again first transcribed in vitro. 
We mixed two species per lane, with the amount of each 
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RNA adjusted to introduce the same. The gel revealed the intermolecular 
interactions between the sRNA and 5' UTR of systems RAJ11 and 
antiRAJ11, as well as the interaction between the two riboregulators. No 
interaction was detected for the non-cognate pairs. 
Functionalization of an antisense small RNA 
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Materials and Methods 
Computational sequence design 
The sequence of the RAJ11 sRNA was used as a template 1. The sequence 
of the antiRAJ11 sRNA was obtained as the negative-sense strand (reverse 
complement) of the RAJ11 sRNA (excluding the transcription terminator). In 
our original designs, the RAJ11 sRNA has the B0015 terminator, and the 
antiRAJ11 sRNA the T500 terminator (see ref. [2] for details). In order to 
design the sequence of the 5' UTR regulated by the antiRAJ11 sRNA, we 
used the web-based software RiboMaker 3 to automatically design regulatory 
RNAs that exploit conformational changes to control gene expression. It uses 
a Monte Carlo simulated annealing optimization algorithm 4 and the 
ViennaRNA package 5 to compute the free energies and secondary 
structures of different species in the system. Here, the system comprised 
three RNA molecules: the small RNA (sRNA), the messenger RNA (mRNA, 
with the 5' UTR), and the interacting complex. To implement this algorithm, 
we constructed a physicochemical model based on free energies and RNA 
structures that included the energies of activation and hybridization 
corresponding to the interaction between the antiRAJ11 sRNA and its 
cognate 5' UTR. The model also accounted for the degree of repression and 
release of the ribosomal binding site (RBS) within the 5' UTR intramolecular 
and intermolecular structures. Successive rounds of random mutations over 
the 5' UTR sequence were applied and selected with an energy-based 
objective function (Fig. S1). Designed sequences are shown in Fig. S2. 
 Ribomaker was run several times to design the 5' UTR responding to 
the antiRAJ11 sRNA. The heuristic algorithm performs multiple cycles of 
random mutations and selection, and each run produces a different 
sequence. The objective function accounts, on one side, on the cis-
repression of the 5' UTR, and, on the other, on the interaction ability with the 
sRNA. Ribomaker outputs the values of effective free energies (to be 
minimized) corresponding to all partial objectives; and the global objective 
function is a sum of these free energies. From all sequences designed, we 
selected the one with minimal value of objective function. 
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In vitro RNA–RNA interaction 
We first constructed the complementary DNAs (cDNAs) of the different RNA 
species of the designed system to then perform in vitro transcription. We 
analyzed the systems RAJ11 and antiRAJ11. We considered the sRNAs 
without transcription terminators and the 5' UTR until the start codon. 
Amplification by polymerase chain reaction (PCR) using Phusion DNA 
polymerase (Thermo Scientific) was done over the template plasmids. The 
PCR products were cloned into the plasmid pUC18, where the restriction site 
Eco31I was previously removed. The resulting plasmids with inserts were 
selected by DNA cleavage with appropriate restriction enzymes. Sequences 
were also verified by sequencing. 
In order to perform in vitro transcription, 3 µg of each pUC18-derived plasmid 
was digested with Eco31I and purified with silica-based columns (Zymo). We 
used approximately 1 µg of digested plasmid in the reaction. The reaction 
mixture (20 µL) contained 10 µL of plasmid, 2 µL of 10x buffer (Roche), 0.4 
µL 10 mM DTT, 1 µL 10 mM NTPs (Thermo Scientific), 0.5 µL Ribolock (~40 
U/µL, Thermo Scientific), 1 µL inorganic pyrophosphatase (0.1 U/µL, Thermo 
Scientific), 1 µL T7 RNA polymerase (50 U/µL, Epicentre), and 4.1 µL H2O. 
We incubated the mix for 1 h at 37 ºC and then added 20 µL of loading buffer 
with formamide. The samples were heated at 95 ºC for 1.5 min, cooled on 
ice, and subsequently separated by polyacrylamide gel electrophoresis 
(PAGE) in a 10% polyacrylamide gel, containing 8 M urea and 1x TBE (200 
V, 2.5 h). The bands corresponding to the full-length RNAs were cut for 
purification. The presence of RNA was confirmed by loading a small part of 
the purified preparations in another polyacrylamide gel. 
For the RNA–RNA interactions, we used approximately the same amount of 
RNA for each of the transcripts (50 ng). The buffer of the reaction was 50 
mM Tris-HCl (pH 7.5), 10 mM MgCl2, and 20 mM NaCl. The mix (20 µL) was 
denatured (1.5 min at 95 ºC) and slowly cooled (15 min at room 
temperature). We then added 1.5 µL glycerol (87%) and 0.2 µL bromophenol 
blue–xylene cyanol (100x) to load the gel (15% polyacrylamide, TAE (tris, 
acetate, and ethylenediaminetetraacetic acid) buffer, 1-mm thick), which was 
run for 2 h at 75 mA at 4 ºC. The gel was stained first with ethidium bromide 
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and then with silver. 
In vitro translation 
PCR was used to prepare DNA for in vitro transcription. T7 promoter was 
added upstream of the expression cassettes consisting of the small RNAs 
(RAJ11 and antiRAJ11 trans elements), or the 5' UTRs (RAJ11 and 
antiRAJ11 cis elements) and fluorescent gene (sfGFP). The primers and 
plasmid templates used are listed below: 
 
 PCR product Primer (forward) Primer (reverse) Template 
DNA 
Amplicon 
size 
1 RAJ11 sRNA T7RAJ11_FW 
5’-TAATACGACTCACTATA 
GGGAGGGTTGATTGTGTGAG-3’ 
T7RAJ11_RW 
5’-GCCTCGCATAAATCTGTCA CAG3’ 
pMIR05  
(this study) 
88 bp 
2 antiRAJ11 sRNA T7antiRAJ11_FW 
5’-TAATACGACTCACTATAGG 
GCCTCGCATAAATCTGTCACAG-3’ 
T7antiRAJ11_RW 
5’-GGGAGGGTTGATTGTGTA AGTC-
3’ 
pMIR03  
(this study) 
90 bp 
3 antiRAJ11 
mRNA 
T7antiRAJ11GFP_FW 
5’-TAATACGACTCACTATAGGGA 
GAGGGAGGGTTCTGTCACT TAATTATTCG-
3’ 
GFP_RW 
5’-AGCGTAATAACTGCAGGAGT 
CACTAA-3’ 
pMIR03  
(this study) 
856 bp 
 
RNA was prepared by transcription using the TranscriptAid T7 High 
Yield Transcription Kit (Thermo Scientific #K0441) and template DNA was 
subsequently removed by DNase I digestion according to the manufacturer’s 
protocol. RNA was purified by extraction once with acid phenol:chloroform 
(1:1) and twice with chloroform:isoamyl alcohol (24:1). The purified RNA was 
used for in vitro translation using the PURExpress In Vitro Protein Synthesis 
Kit (New England Biolabs #E6800S). Each mRNA and sRNA was used at 
end concentration of 10 nM and 10 µM, respectively. The reaction volumes 
were scaled down to 10 µL each and prepared at 4 °C. The reactions were 
incubated at 37 °C, and green fluorescence was monitored using the 
Mx3005P qPCR System (Agilent Technologies) with filter set FAM/SYBR 
Green I (492 nm - 516 nm) (Fig. S8). 
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Supplementary Figures 
 
Figure S1: Scheme of the optimization loop to obtain a 5' UTR sequence able 
to interact with the antiRAJ11 sRNA, whose sequence is kept fixed. 
 
 
 
Figure S2: Sequences of the RNA species. 
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Figure S3: Maps of the plasmids used in this work for expressing the 
designed sRNA 
systems. 
 
 
Figure S4: Maps of the plasmids used in this work for expressing the 
designed sRNA 
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systems. 
 
Figure S5: Maps of additional plasmids used in this work for studying the 
orthogonality of the designed sRNA systems. 
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Figure S6: Characterization result of antiRAJ11 system by flow cytometry 
which shows the behavior at the single-cell level. 
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Figure S7: Scheme of the regulatory circuit and characterization result of antiRAJ11 sRNA 
inhibition of the action of RAJ11 sRNA. Here, + (or −) means that the antiRAJ11 sRNA is (or 
is not) present (introduced with a different plasmid). Assays performed in JS006 cells. 
 
Figure S8: On the left, dynamics of in vitro translation (three replicates) for different 
combinations of RNAs (pre-transcribed). On the right, stationary behavior (background 
subtraction). 
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Figure S9: Scheme of the regulatory circuit and characterization result of antiRAJ11 sRNA 
transactivation of cis-repressed GFP by RAJ11 5' UTR. + stands for an assay where the 
sRNA is expressed (performed in JS006 cells or with aTc in MGZ1 cells), while - for an 
assay where the sRNA is highly repressed (performed in MGZ1 cells). 
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Figure S10: Scheme of the regulatory circuit and characterization result of RAJ11 sRNA 
transactivation of cis-repressed GFP by antiRAJ11 5' UTR. + stands for an assay where the 
sRNA is expressed (performed in JS006 cells or with IPTG in MGZ1 cells), whilst - for an 
assay where the sRNA is highly repressed (performed in MGZ1 cells). 
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PCR was used to prepare DNA for in vitro transcription. T7 promoter was 
added upstream of the expression cassettes consisting of the small RNAs 
(RAJ11 and antiRAJ11 trans elements), or the 5' UTRs (RAJ11 and 
antiRAJ11 cis elements) and fluorescent gene (sfGFP). The primers and 
plasmid templates used are listed below: 
 
 PCR product Primer (forward) Primer (reverse) Template 
DNA 
Amplicon 
size 
1 RAJ11 sRNA T7RAJ11_FW 
5’-TAATACGACTCACTATA 
GGGAGGGTTGATTGTGTGAG-3’ 
T7RAJ11_RW 
5’-GCCTCGCATAAATCTGTCA CAG3’ 
pMIR05  
(this study) 
88 bp 
2 antiRAJ11 sRNA T7antiRAJ11_FW 
5’-TAATACGACTCACTATAGG 
GCCTCGCATAAATCTGTCACAG-3’ 
T7antiRAJ11_RW 
5’-GGGAGGGTTGATTGTGTA AGTC-
3’ 
pMIR03  
(this study) 
90 bp 
3 antiRAJ11 
mRNA 
T7antiRAJ11GFP_FW 
5’-TAATACGACTCACTATAGGGA 
GAGGGAGGGTTCTGTCACT TAATTATTCG-
3’ 
GFP_RW 
5’-AGCGTAATAACTGCAGGAGT 
CACTAA-3’ 
pMIR03  
(this study) 
856 bp 
 
RNA was prepared by transcription using the TranscriptAid T7 High Yield 
Transcription Kit (Thermo Scientific #K0441) and template DNA was 
subsequently removed by DNase I digestion according to the manufacturer’s 
protocol. RNA was purified by extraction once with acid phenol: chloroform 
(1:1) and twice with chloroform: isoamyl alcohol (24:1). The purified RNA 
was used for in vitro translation using the PURExpress In Vitro Protein 
Synthesis Kit (New England Biolabs #E6800S). Each mRNA and sRNA were 
used at end concentration of 10 nM and 10 µM, respectively. The reaction 
volumes were scaled down to 10 µL each and prepared at 4 °C. The 
reactions were incubated at 37 °C, and green fluorescence was monitored 
using the Mx3005P qPCR System (Agilent Technologies) with filter set 
FAM/SYBR Green I (492 nm - 516 nm) (Fig. S8). 
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Chapter 3 
 
Engineering trans-activating multi-component 
riboswitches 
 
Schematic of Multicomponent RNA switch 
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3.1 Abstract 
Living cells rely on small non-coding RNAs (sRNAs) to regulate gene 
expression at the post-transcriptional level. Contrary to most protein-based 
activators of transcription, the riboregulators, known till date, do not exploit 
cooperative binding mechanism to activate gene expression. We conceived 
a general strategy to design trans-activating multicomponent riboswitches by 
programming a hierarchical toehold activation cascade, which we 
implemented to develop a de novo sequence design algorithm. We 
engineered different trans-activating multicomponent riboswitches   systems 
relying on the conditional formation of a heterotrimeric species. We 
characterized the specificity of each RNA-RNA interaction in vitro and the 
cooperative activation of gene expression in Escherichia coli. As we only rely 
on a biochemical model to compute allosteric regulation, our strategy could 
be applied to reach more complex RNA-based nanostructures regulating 
gene expression for synthetic biology applications. 
3.2 Introduction 
Trans-activating multicomponent riboswitches (Cooperative riboswitches) 
interactions at the molecular level are crucial factors for the living systems in 
order to sustain complex behaviors (Strogatz 2001). Indeed, the control 
mechanisms of gene expression found in higher organisms (e.g., mammals) 
present many cellular factors at play and are highly combinatorial (Ravasi et 
al. 2010), but most of these are limited to protein interactions. As nucleic 
acids are molecules with more programmable interactions than proteins, they 
prove to be better material for nanotechnology to engineer complex 
nanostructures, conceived by designing interactions using toehold-mediated 
strand-displacement reactions (Yin et al. 2008, Afonin et al 2010). However, 
RNAs have not yet been engineered to control gene expression in a 
sophisticated manner in living cells. 
In this study, I considered RNA as a substrate to design and characterize 
cooperative riboregulators of gene expression, exploiting a physicochemical 
model involving free energies and secondary structures. Previous work in our 
lab (Jaramillo lab) on the de novo design of synthetic regulatory RNAs has 
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allowed the engineering of new systems to control protein expression in 
living cells (Isaacs et al., 2004; Tucker and Breaker, 2005; Blount and 
Breaker, 2006; Rodrigo et al., 2012; Na et al., 2013). Here, I went beyond by 
designing obligate heterodimers of sRNAs activating the initiation of 
translation. There are one reports (Green and Collins 2014) till date that 
reports natural or synthetic riboregulators to be able to regulate gene 
expression in microbes, cooperatively. Although, there are a few studies on 
higher organisms, regarding the synergistic repression of microRNAs with 
target sites optimally separated (between 8 and 40 nucleotides) (Grimson et 
al., 2007). The present piece of work, in addition illustrates the designability 
of synthetic Trans-activating multi-component riboswitches, provides 
experimental evidence for combinatorial mechanisms employed by microbial 
riboregulome.  
To design Trans-activating multi-component riboswitches, we exploited the 
facts that i) RNA-RNA interactions are kinetically dominated by a toehold-
mediated mechanism (i.e., interacting regions remain unpaired within the 
intramolecular structures of the species), ii) the ribosome-binding site (RBS) 
of a given mRNA can be considered as a toehold mediating the its 
interaction with the ribosome, and iii) activating toeholds in cascades 
implement a hierarchical assembly of higher-order complexes (Rodrigo et al., 
2012). We propose programming RNA species holding hidden/inactive 
toehold domains that become active after a conformational change following 
a binary interaction. Once the toehold is active, the complex is able to 
interact with a third RNA specie. The energy landscape associated with our 
hypothesized hierarchical interaction mechanism is shown in Figure 3.2.  
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Figure 3.1 Design of a trans-activating multicomponent riboswitches plasmid. The sRNA1 
(coop A) is controlled by PLlacO1 promoter and sRNA2 (coopB) is regulated by PLtetO1 
promoter. The Cis-repress 5’UTR (coopU) is under the control of a constitutive promoter, 
BBa_J23119. The super-folder GFP with degradation tag fused with the 5’ UTR. 
To control the gene expression, we used a trans-acting riboswitch, able to 
activate a cis-repressed 5’UTR of a given messenger RNA (mRNA), via 
allosteric regulation (Isaacs et al., 2004; Rodrigo et al., 2012; Na et al., 
2013). We identified different conformational states and their free energy 
levels, which could be predicted with a physicochemical RNA model 
(Hofacker et al., 1994; Mathews et al., 2004; Wright et al., 2014). The 
reaction coordinate was defined as the number of intermolecular hydrogen 
bonds (or base pairs), on one side, between the two sRNAs (sRNA1-coopA 
and sRNA2-coopB, hereafter) and, on the other side, between the resulting 
sRNA complex and the 5’ UTR of the target mRNA (coopU, hereafter). On 
the energy landscape, two barriers (free energies of activation; DG1#and 
DG2#) impinge the progression of the reaction, one for each intermolecular 
interaction that defines the reaction coordinate. These free energies of 
activation are associated with the degree of exposition of the toeholds to the 
solvent, and shall be low (i.e., three or more nucleotides shall be unpaired in 
the toehold (Rodrigo et al., 2013;) to permit the initiation of the reaction 
(kinetic aspect). In addition, for an efficient reaction, the free energies of 
hybridization (DG1 and DG2) have to be as low as possible (at least, lower 
than -15 Kcal/mol (Rodrigo et al., 2012;) to ensure irreversibility in the 
intermolecular interactions (thermodynamic aspect) (Laidler et.al., 1983).  
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Figure 3.2 Energy landscape of Trans-activating multi-component 
riboswitches (cooperative riboswitches) of gene expression in bacterial cells. 
On left top, the objective function to be minimized is explicated. The terms 
DG1, DG1#, DG2, and DG2# correspond to the free energies of hybridization 
and activation, respectively, between the two sRNAs (subscript 1) and 
between the sRNA complex (heterodimer) and the 5’ UTR (subscript 2). Note 
that the free energy of hybridization is a negative magnitude, whereas the 
free energy of activation is a positive magnitude. The terms DGˆi and DGˆi# 
correspond to the free energies of hybridization and activation, respectively, 
between the sRNA i and the 5’ UTR (subscript i = 1 or 2, for coopA or coop 
B). They have to be maximized in order to be maintained in negative 
magnitude. Finally, the terms DG 5'UTR complexstruct and DG 5’ UTRstruct 
are the works required to fold 5' UTR complex the 5’ UTR (coopU) and the 
heterotrimer according to the structure specifications (in this case, RBS is 
paired in the 5’ UTR and unpaired in the complex). On right top, the scheme 
of the optimization loop is depicted, where three RNA sequences (coopA, 
coopB, and coopU) are iteratively mutated and evaluated according to the 
objective function. The energy landscape shows the different conformational 
states (intra- and intermolecular), together with the free energy terms of the 
objective function, as a function of a reaction coordinate (number of 
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intermolecular base pairs). The trajectory illustrates the interaction between 
two sRNAs to form a heterodimer that is able to subsequently interact with 
the 5’ UTR to release the RBS and then allow translation.  
To show that the proposed hierarchical toehold activation mechanism (based 
on the kinetic aspect) is a sufficient criterion to provide arbitrary cooperative 
riboregulation, we developed a computational algorithm (with collaboration 
Dr. Rodirgo, Spain) that addressed the de novo sequence design (iterative 
process of random mutations and selection according to an energy-based 
objective function) Figure3.2 (Rodrigo et al., 2012, Rodrigo et al., 2013). The 
objective function was calculated with a nucleotide-level energy model 
considering all conformational states of the system’s species (coopA, coopB, 
coopU, all possible heterodimers, and the heterotrimer), following a 
combined strategy of positive and negative design (Koga et al., 2012). On 
one hand, as positive objectives (to be minimized), we considered the free 
energies of activation and hybridization corresponding to the interactions 
between the two sRNAs and between the resulting sRNA complex and the 5’ 
UTR. We also considered the intramolecular structure of the 5’ UTR (to have 
the RBS paired), and the intermolecular structure of the 5’ UTR with the 
sRNA complex (to have the RBS unpaired). On the other hand, as negative 
objectives (to be maximized), we took the free energies of activation and 
hybridization corresponding to the interactions between each sRNA and the 
5’ UTR.  
We computationally designed two systems: (coop1 and coop2) (Table 1). 
System coop1 was obtained by specifying the intramolecular structures of 
the two sRNAs, whereas for system coop2, the specification was of the 
intermolecular structure of the sRNA complex (introduced as soft constraints 
in both cases). These specifications, although were not required functionally, 
were introduced to prevent premature degradation of unstructured sRNAs. 
For these systems, the toehold that nucleates the interaction between coop1: 
coop2 and coopU is hidden within the intramolecular structure of coop1 (or 
coop2). However, the toehold that nucleates the interaction between coop1 
and coop2 (or coopA2 and coopB2) is unpaired (active) within their 
intramolecular structures, so that the hybridization reaction between both 
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sRNAs becomes feasible. As a result, within the intermolecular structure of 
the resulting sRNA complex, the toehold that nucleates the interaction with 
coopU (or coopU2) becomes active. The structures of system coop2 are 
shown in Figure 3.2 explaing the hierarchical activation of toeholds.  
However, even if a toehold is not hidden within the corresponding 
intramolecular structure sRNA1 (of coopA), it may still remain inactive. In this 
case, the hybridization free energy would not be sufficient to ensure 
irreversible interaction (with coopU), and an additional species sRNA2 
(coopB) would be required for the reaction. The free energy of hybridization 
between coopA: coopB and coopU would then be sufficient to form the triple 
intermolecular folding state with a three-way junction. To explore this 
possibility (based on the thermodynamic aspect), we considered a design 
based on a three-way junction. Indeed, naturally occurring three-way 
junctions have already been exploited to engineer RNA-based structure.  
We took advantage of our previously published riboregulatory systems, 
RAJ11 and RAJ12 (Rodrigo et al., 2012). We split the sRNA into two halves, 
coopA11 and coopB11 hereafter, and considered the cognate 5’ UTR, which 
we named here as coopU11 (figure3.2). The free energies of hybridization 
were automatically fair due to the three- way junction formed within the 
intermolecular conformation between the sRNA and 5’ UTR in the native 
system, RAJ11. While constructing coopA11 and coopB11, we found that 
both sRNAs had an active toehold that allowed them to interact. The 
heterodimer coopA11: coopB11 has another active toehold that nucleates it’s 
binding to coopU11 by forming a heterotrimer with the three-way junction. 
This resulting structure activates the RBS for recognition by the ribosome 
and then initiates translation. The coop12 system did not work after splitting 
into two parts of small RNA. 
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Figure 3.3 showing Sequences and structures of the species of the designed sRNA system 
coop2. The toehold for the interaction between the two sRNAs is shown in blue. The toehold 
for the interaction between the heterodimer (sRNA complex) and the 5’ UTR is shown in red. 
In the 5’ UTR (cCoopU2), the RBS is shown in yellow. The transcription terminators T500 
and B1002 were used in coopA2 and coopB2, respectively. As shown in the figure, toehold 
is inactive in sRNA1 (coopA). The sRNA2 (coopB) is also inactive. The two small RNAs 
hybridize and make heterodimer and toehold is free. This heterodimer hybridizes to cis-
repress. 5’UTR (coopU) change the conformation and expose RBS and make hetrotrimer 
and a three-way junction. This system also explains the AND logic circuits. 
We performed in a PAGE gel the molecular characterization of the higher-
order RNA-RNA interactions by gel analysis (Shu et al., 2011). The different 
RNA species were first transcribed in vitro (for the sRNA species without 
transcription terminators). We prepared, in each lane, the three-individual 
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species: coopU, coopA, and coopB. Then, we prepared the three possible 
combinations of two species and finally, the three species together. The gel 
finely shown for system coop11, the intermolecular interactions i) between 
the two sRNAs, and ii) between the resulting sRNA complex and the 5’ UTR 
(Figure 3.4). It also revealed mild intermolecular interaction between one 
sRNA and the 5’ UTR (Figure3.4). We also confirmed the intermolecular 
interactions between the sRNA complex and the 5’ UTR for system Coop11 
by PAGE. Taken together, these results validated our description of the 
energy landscape.  
The designed RNA systems were implemented as separate operons (with 
their respective transcriptional terminators) in plasmids, which were 
transformed in E. coli strains, expressing the transcriptional repressors LacI 
and TetR (illustrates the engineered sRNA circuit). The use of PL-based 
inducible promoters allowed controlling the expression of the two sRNAs with 
the external inducers, isopropyl-β-D-thiogalactopyranoside (IPTG) and 
anhydrotetracycline (aTc) (Lutz and Bujard 1997) Figure 3.5 shows the 
dynamic ranges (characterized by fluorimeter) of our engineered systems, 
probing the regulation of gene expression in living cells with two cooperative 
sRNAs (at the population level). To assess that the combined action of the 
two sRNAs was enhanced over the expected action from their independent 
contributions, we compared the increase in gene expression with both 
inducers with respect to the additive increase with IPTG, on one side, and 
aTc, on the other (Welch t-test, P < 0.02 for systems, coop11 and coop2; and 
P = 0.06 for system, coop1). We also observed that cis-repression is much 
stronger in systems coop11 and coop1 than in system coop2. Figure3.3 
demonstrated a graded response with both the inducers. To further explore 
the cooperative behavior at single cell level, we performed a time- dependent 
characterization of system coop11 (in Dh5alphaproZ1 E. coli strain) and 
coop2 (MG1655Z1) using microfluidic devices Figure 3.8 (Bennett and Hasty 
2009). This allowed us to monitor GFP expression in single cells under a 
varying concentration of both the inducers Figure 3,8 B. These results 
showed that each individual cell responded to the inducers, and that the 
system, as expected, is reversible in vivo. Flow cytometry experiments 
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also revealed significant population shift in response to both the inducers 
Figure 3.7.  
In conclusion, we programmed with RNA, a hierarchical activation of hidden 
toeholds after intermolecular interactions (systems coop1 and coop2; 
sequences obtained by computational design). Cooperative behavior can 
also be programmed without relying on the activation of a hidden toehold 
when forming the obligate heterodimer if a thermodynamically stable three-
way junction is used (system coop11). This coupling between hierarchical 
assemblies of RNA structures with gene expression could allow the 
application of known nano- structures (Bhadra and Ellington 2014) to 
engineer the higher-order regulation of gene expression in living cells, and 
potentially novel trans-activating multicomponent riboswitches with 
sophisticated functionalities.  
Engineering of New RNA molecule (regazyme)  
In our lab we engineer synthetic transduction system. (Shen et.al.,2015) We 
developed small RNA based sensing. In this work I fused small RNA-RAJ11 
with theophylline aptamer to engineer the novel sensing system. This 
aptazyme acting as a moleculer sensing elements (regazyme). In the 
presence of theophylline, aptazyme cleave and release riboregulator (small 
RNA). This sRNA binds to cis-regulated mRNA and expressed GFP 
 
 
 
 115 
 
 
Figure 3.3 B Functional characterization of small-molecule-sensing regazyme 
Figure 3.3B Schemes of the engineered RNA-based circuit to sense a small molecule and 
its corresponding control. (Digital scheme, associated Truth table, and fluorescence results 
of regazyme theoHHAzRAJ12. 
The figure Adapted Shen, Rodirgo and Prakash et al. NAR 2015 
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Figure 3.3 C Molecular characterization of small-molecule-sensing regazyme. 
Figure 3.5 SequenceandstructureoftheregazymetheoHHAzRAJ12.Asmallmolecule (Theo) 
binds to the regazyme to reconstitute the active conformation of the ribozyme and then 
produce the cleavage. An arrow marks the cleavage site, between the transducer module 
and the ribozyme core. The seed of the riboregulator is paired in the uncleaved state. (B) 
Time-dependent electrophoretic analysis of cellular RNA extracts taken at different time 
points; gel shown for 4 mM Theo. Quantification of dynamic RNA processing for different 
concentrations of the signal molecule (Theo). Data fitted with a generalized exponential 
decay model with production, where the temporal factor is (1 − exp(−λt))m, with m ≈ 1. Error 
bars represent standard deviations over replicates. 
The figure Adapted Shen, Rodirgo and Prakash et al. NAR 2015 
3. 3 Results discussion 
The thermodynamic model to create trans-activating 
multicomponent riboswitches (cooperative riboswitches)  
We engineered a cascade of three RNA molecules (Fig3.3). The small RNA1 
(coop1) is able to interact with sRNA2 (coop2). The coop2 is initially in ‘off’ 
state because toehold hidden and inactive. The binding of coop1 to coop2 
changes the conformation and thus activates the toehold. This coop1: coop2 
heterodimer interacts with the inactive 5’UTR (coopU) and forms a 
heterotrimer. This heterodimer binding to 5’UTR changes the conformation 
and exposes the RBS, which then allows the landing of ribosome and thus 
translation initiation factors start translation. This strategy leads to the 
formation of larger cascades at post- transcriptional level. The energy 
landscape associated to our hypothesized hierarchical interaction 
mechanism is depicted in Figure 3.2  
RNA-RNA interaction in-vitro (PAGE) 
To get mechanistic insight about the regulatory behavior, we characterized 
the higher- order RNA-RNA interactions by polyacrylamide gel 
electrophoresis (PAGE). The complementary DNAs (cDNAs) corresponding 
to the RNA species were first transcribed in vitro (for the sRNA species 
without transcription terminators), then purified and quantified. We 
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mixed the three-individual species (coopU, coopA, and coopB), and all 
combinations of two of these species. These mixes, along with the individual 
RNAs as controls, were loaded in polyacrylamide gels and separated 
electrophoretically. The PAGE gel shown for coop system  
 
 
 
 
Figure 3.4 Electrophoretic analysis of system Coop11. The different lanes correspond to all 
combinations of species. The arrow marks the complex of the three RNAs. PAGE gel 
showing RNA –RNA interaction between coop11A, coop11B and coop11U.   
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Characterization of trans-activating multicomponent 
riboswitches   
 
 
!
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Figure 3.6 Functional characterization of trans-activating multicomponent 
riboswitches (cooperative riboswitches) systems in bacterial cells. (a) Digital-
like scheme of the engineered sRNA circuit. Promoters PLlacO1 and 
PLtetO1 control the expression of the two sRNAs, which can be tuned with 
external inducers IPTG and aTc, whereas the mRNA is constitutively 
expressed from promoter BBa_J23119.  
To test variability and reproducibility, I characterized cooperative 
riboregulators in different E. coli strain (MG1655Z1, Dh5alphaproZ1 and 
JS006). I characterized in technical and biological replicate and in different 
days. As Shown in figure1.5.  Fluorescence results of the designed systems 
Coop11, Coop1, Coop2, coop3 and coop 12.  The characterization in all four 
possible combinations of inducers (none, aTc, IPTG, aTc+IPTG) Error bars 
represents standard deviations over replicates.  As results showing coop1 
(sRNA1) hybridized to coop2 (sRNA2). This heterodimer bind to coopU (cis-
repress 5’UTR) and change the conformation open RBS and express 
reporter protein. As results showing some riboregulators giving very good 
expression and some giving poor expression.  
To assess that the combined action of the two sRNAs was enhanced over 
the expected action from their independent contributions, we compared the 
increase in gene expression with both inducers with respect to the additive 
increase with IPTG, on one side, and aTc, on the other (Welch t-test, P < 
0.02 for systems Coop11 and Coop2; and P = 0.06 for system Coop1). We 
also observed that cis-repression is much stronger in systems Coop11 and 
Coop1 than in system Coop2. Figure 3c demonstrated a graded response 
with both inducers Figure 3.7 showing dynamic range of both inducer aTc 
and IPTG. 
Functional characterization of trans-activating multicomponent riboswitches 
in JS006 E. coli Figure 3.8. The JS006 E. coli strain have no is the lacQ, - 
tetR-. This strain always expresses both coop RNA that I deleted sRNA2 
(coop2).  Results showing that in presence of both coopA and coopB, the 
coopU is active and GFP are express. In the absence of sRNA2 (coopB), 
toehold is inactive and cis –repress 5’ UTR inactive and no GFP exprees. 
 
 
 121 
 
 
  
Orthogonality of cooperative riboregulator. I also cheked the interaction of 
RNA with in circuits and crosstalk with in the cis and transRNA. 
Flow-cytometry characterization trans-activating 
multicomponent riboswitches.  
Flow cytometry experiments revealed significant bacterial population shift in 
response to both inducers (Figure 3.9A. results of trans-activating 
multicomponent riboswitches). The reported dynamic ranges at the single-
cell level are similar to those measured for the whole population.  
These results showed that every individual cell responds to the inducers, and 
that the system, as expected, is reversible in vivo. Flow-cytometric results for 
system Coop2 for all possible combinations of inducers (none, aTc 
(100ng/ml), IPTG (1mM) and (aTc+IPTG) in MG1655Z1 E. coli strain. The 
black curve corresponds to plain cells. 
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Study of single cell dynamics of trans-activating 
multicomponent riboswitches. 
To further explore the cooperative riboregulatory behavior at the single-cell 
level, we performed a time-dependent characterization of system coop11 
and coop2 using microfluidic lab-on- chip devices Figure 3.10). This allowed 
us to monitor GFP expression in individual cells under a varying 
concentration of both inducers. Single cell tracking of fluorescence [GFP 
expression in arbitrary fluorescence units (AFU)] in one micro-chamber of the 
microfluidics device under time-dependent induction with IPTG (1 mM) and 
aTc (100 ng/mL) for system Coop2 in MG1655Z1 and coop11 in 
Dh5alphaproZ1. A square wave of both inducers with period 8 h (i.e., 4 h 
induction and 4 h relaxation) was applied. The solid and dashed lines (in 
blue) correspond to the mean and plus/minus standard deviation over the 
cell population. Sulforhodamine B was used to monitor the inducer time-
dependent profile (in red). The (Figure 3.10a) showing chamber of PDMS 
CHIP.  
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(Figure 3.10 B) showing single cell tracking of GFP of trans-activating 
multicomponent riboswitches Coop11 in Dh5alpharoZ1. 
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Figure 3.11 We have engineered a new type of RNA molecule (regazyme) 
that does not exist in nature, and experimentally validated in lab This 
“regazyme” molecule combines a riboregulator and a ribozyme, and gets 
activated in the presence of a small molecule.  The system produces green 
fluorescence when all three molecules (ligand, small RNA and mRNA-GFP) 
are present. (Shen et.al 2015) 
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Chapter 4 
Discussion and conclusion. 
Nucleic acids are molecules with a much higher interaction programmability 
than proteins.  The overall aim of my research is to engineer trans-activated 
RNA switch that would be useful for reprogram cell, RNA sensing, reduce the 
metabolic load, to evolve future medically applicable new biomolecule and 
devolve anti-terminator system trans-activated RNA switches cascade-based 
feedforward loop. In order to do this, we engineered a trans-activated 
tuneable antiterminator RNA switch. The engineering of the trans-activating 
RNA switches was done in E. coli. RNA-switches i.e., riboregulators that are 
ON/OFF in terms of activity according to the binding with another RNA. 
These are hence new elements offering new possibilities for engineering 
functional, synthetic gene circuits in living cells. In addition, as these circuits 
would be mainly based on physical interactions between RNAs, their 
adaptation to other organisms than E. coli (including eukaryotic hosts) might 
be favored by only re-designing the interface with the output-protein-
expression machinery (either at transcriptional or post-transcriptional level). 
To design our RNA switches we used a computational and rational design. 
For the trans-activating RNA switches, we used a small RNA that works as 
an antiterminator element. The small RNA acts as an adapter converting a 
translational signal into a transcriptional one. The small RNA hybridizes with 
a cis-repressed mRNA, this interaction free up an RBS, allowing the 
ribosome to bind and initiate translation (Figure 1.2).  We have successfully 
been able to engineer an antiterminator RNA switch. We tested a library of 
terminators (table 1.1) and shown that they are working well (figure 1.4). To 
further justify our hypothesis, we tuned our system with different RBS 
strengths (from weak RBS to strong and including a no RBS control).  Our 
results in figure 1.7 show that translation-transcription coupling is directly 
controlled by the RBS. Strong RBS’s convert more signal and weaker RBS’s 
convert less, and our no RBS no signal is converted to translation to 
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transcription. In order to explain our hypothesis, I made a knockout of the 
‘ATG’ start codon, replaced with ‘AAG’. The idea was that if ATG is deleted 
then translation would does not start even ribosome is land on RBS for 
translation. But we do not get any difference in the GFP expression in the 
Wild type and ATG knockout. We hypothesized that the start codon and the 
terminator are very close, and that even after the deletion of ‘ATG’ nascent 
mRNA RNA is very small and unable to make a hairpin stem loop. This allow 
translation continue on terminator sequence and GFP expressed. To combat 
this, we inserted a 30 to 45 bp spacers between the ‘ATG’ and terminator 
(figure 1.10).  After insertion of spacer the ‘ATG’ knockouts show no 
expression in no, but wild type strain shows GFP expression with IPTG 
induction. Alongside this we made the control system of a constitutive RBS 
and spacer, and our results show that if the RBS is present then the system 
expresses GFP. We also tested our antiterminator system with Isaac’s 
riboregulators RR12 (Issacs and Collins 2006) (figure1.12). The system does 
not work well. We further engineered a complex feedforward loop system, 
the TNA31cascade. The results are not as we hypotheses. This could be 
possibly two RNA interfere each-other, they may have cross talk or the 
system could be leaky.  
To further explore the possibility to construct antiterminator riboswitch. 
Theophylline riboswitch (Lynch et. al 2007) based system was design and 
validates and (figure 1.7 A &B and 1.8). The Fluorimeter characterization and 
single cell dynamics results explains system working well.  After 
experimentally validating theophylline riboswitch based antiterminator. I 
designed and characterized double riboswitch based cascade      
(feedforward loop based). The results explain (figure1.8 and figure 1.9). but 
system does not work. Possibly two riboswitches could interfere each other 
or two inducers may be toxic to cell or interfering each other.  We need to 
engineer much robust system (riboswitch) to engineer feedforward and 
feedback loop. For this end we are developing directed evolution system. 
The system will be based on PACE phage assistance evolution. In our case 
T7 bacteriophage using as an evolution tool. Bacteriophages are viruses of 
bacteria that infect and often kill them. Viruses have faster mutation and 
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adaptation rates for new environment than the cells they infect. Therefore, 
we use T7 bacteriophage as a tool for evolution to make novel biomolecule 
such as better riboswitch or new riboswitch. We have integrated our 
riboswitch for evolution in the T7 bacteriophage genome. We design the 
system in a way that riboswitch function directly controls the rate of 
bacteriophage propagation. This results in the cargo molecule being 
evolved to become better in its function. We engineered T7 riboswitch 
recombinant bacteriophage engineered.  
 
Figure 4. 1Design of T7 recombinant phage with riboswitch. 
 
Figure 4.2 Design of bioreactor to evolve new riboswitch/ better riboswitch.  
In the 2nd part of my research we engineered a trans-activated single 
component RNA switch (Rodirgo et.al 2016). Here, we hypothesized that it 
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should be possible to engineer a synthetic sequence, where it would be 
possible to produce a different riboregulator when transcribed in each sense. 
We are able to engineer a reverse complement of known a riboregulator.  
We used computational design to create a cis-repressed 5’UTR. In our 
design one DNA template is able to transcribe two small RNA depends on 
the direction of transcription. These are activated by two genes 
independently. In conclusion this overlapping reading frames can have 
transcribed two transcript and reduce the information encoded in the genome 
and metabolic load on cell.  
Our results also explain (figure 2.3), if two promoter face to face each other 
than transcription of both transcript sRNA-RAJ11 and sRNAanti-RJA11 is not 
possible at the same time on the same DNA template. This is due to both 
promoter’s competition, only the stronger could win. The two promoters also 
collide finally the canceled to each other or incomplete transcription. We also 
hypothesized ambisense based on ribozyme figure 2.5. According to results 
figure 2.5, the ribozyme ambisense RNA switches are leaky, it is likely both 
sRNAs are not transcribed properly. Finally, we have demonstrated that it is 
possible to use an antisense sRNA as a new regulatory agent in the cell. 
This was accomplished by designing an appropriate 5′ UTR. These results 
largely indicate the development of sophisticated RNA-only circuits where 
sRNAs interact with each other to form arbitrary regulatory architectures. We 
also hypothesize that antisense transcripts could be exploited in synthetic 
biology as overlapping reading frames of transcription (i.e., ambisense) for 
engineering bi-functional systems with minimal genetic material, as well as 
non-linear behavior with RNA, as convergent transcription has been shown 
to confer a bistability. We are able to transcribe two RNA switch that activate 
two gene independently and that also cancel each other if both are present. 
In order to engineer minimum genetic material for reduction of the metabolic 
load on cells we constructed a single component RNA switch with reduced 
nucleotide usage. This switch created with three nucleotides only (G, C and 
U) (unpublished results). This RNA switch without adenine.  
In order to engineer, a robust system to reduce metabolic load on the host 
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cell RNA switch does not having crosstalk with host cell. To This end I tested 
orthogonality of our RNA switch. Our results in figure 2.30 explains that our 
RNA switch does not having crosstalk to other RNA and within the host cell.  
 
In 3rd chapter of my thesis we engineered a multi-input trans activating RNA 
switch. We programmed RNA with a hierarchical activation of hidden 
toeholds, after intermolecular interactions (Coop1 and Coop2; sequences 
obtained by computational design) Cooperative behavior of RNA switch can 
also be programmed without relying on the activation of a hidden toeholds 
when forming the obligate heterodimer (Rodirgo et.al.2017) if a 
thermodynamically stable three-way junction can be used (system Coop11) 
(figure 3.2). This coupling between hierarchical assembly of RNA structures 
with gene expression could allow the application of known nanotechnology 
structures to engineer higher-order regulation of gene expression in living 
cells. This will contribute to have building blocks with increased nonlinearity, 
and potentially to create novel RNA circuits with sophisticated functionalities. 
We characterized multicomponent RNA switch in different dynamic range. 
We study reporter protein expression at both the single cell and population 
level. Additionally, we studied possible molecular interaction between 
different component of RNA with PAGE figure 3.4. We also study single cell 
dynamics of our system in MG1655Z1 and Dh5alphaproZ1 strain.  
We have designed and experimentally validated new type of RNA 
molecule(regazyme). This is the chimera of an aptazyme with a 
riboregulator. The regazyme sensing a ligand (theophylline) self-cleaves and 
releases a riboregulating small RNA (Shen et al., 2105). This small RNA 
binds to a cis-repressed mRNA allowing translation of a reporter protein. The 
regazyme able to transduce signals in a modular way in live cells, introducing 
the one-to-two-component signal transduction paradigm. The design strategy 
relies on the hierarchical activation/inactivation of RNA elements with specific 
function. In our case we developed theophylline-based signal transduction 
system. The ligand should be different and we can develop more regazyme 
with different ligand or environment signal. 
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We have engineered RNA based synthetic signal transduction cascade 
consisting of a single RNA molecule (Regazyme, an RNA chimera of an 
aptazyme with a riboregulator) that upon sensing a ligand (theophylline) self-
cleaves and releases a riboregulating small RNA (Shen et al., 2105). The 
regazyme able to transduce signals in a modular way in live cells, introducing 
the one-to-two-component signal transduction paradigm. The design strategy 
relies on the hierarchical activation/inactivation of RNA elements with specific 
function. In our case we developed theophylline-based signal transduction 
system. This system can be adapted to be induced by other ligands and can 
be used as a biosensor.  
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Apendix1 
Sequence used in this work 
Plasmid sequenced of chapter1 
Sequence and plasmid map. This is the sequence of functional part. 
The plasmid backbone, reporter protein, antibiotics marker is same as 
pSTC1 in chapter1. The sequence having colour code accordind to their 
order. 
1. EcoR1+ T500+ (sRNARAJ11) REV +(Promoter PLacO1) Rev + 
PromoterJ23119 
+ 5’UTR-RAJ11 +Terminator B1002+ B0034 RBS 
gaattcAAAAAAAATCCTTAGCTTTCGCTAAGGATGCCTCGCATAATCA
CACAATCAACCCTCCCGTGCTCAGTATCTTGTTATCCGCTCACAAT
GTCAATGTTATCCGCTCACATTTtctagaTTGACAGCTAGCTCAGTCCT
AGGTATAATGCTAGCCCTCGCATAATTTCACTTCTTCAATCCTCCCG
TTAAAGAGGAGAAATTATGAATGggatccCGCAAAAAACCCCGCTTCG
GCGGGGTTTTTTCGCAATAAATTAAAGAGGAGAAAGGTACCATG+S
pe1 + SfGFP 
TNA_T500 (terminator) 
CAAAGCCCGCCGAAAGGCGGGCTTTTCTGT 
 
TNA_B1002 (terminator) 
 
CGCAAAAAACCCCGCTTCGGCGGGGTTTTTTCGC 
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>TilvGEDA (terminator, very good according to Endy et al.) 
 
TAGAGATCAAGCCTTAACGAACTAAGACCCCCGCACCGAAAGGTCCGG
GGGTTTTTTTTGACCTTAAAAACATAACCGAGGAGCAGACA 
 
>mutated version of TilvGEDA (to remove stop codon) 
 
E. coli DH5 -Z1 Commercial (DH5   lacIQ, PN25-tetR, 
SpR) 
Clontech 
E. coli MG1655-
Z1 
lacIQ, PN25-tetR, SpR Gifted by 
M.B. Elowitz 
P-TNA B1002  pSC101m ori, kanR, sfGFP-LAA This work  
P-TNAttonb pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA-TFUR pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA RefTFUR pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA-21 pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA -T500 pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA-TNA31 pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA TNA 12 pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA double 
riboswitch 
pSC101m ori, kanR, sfGFP-LAA This work 
P-TNA FFL pSC101m ori, kanR, sfGFP-LAA This work 
 
 
 
 
Plasmid sequence of Chapter2 
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1. Design of compact ambisense Riboregulators  
>E + rev(TrrnC) + PLlacO1 + transRAJ11 + rev(PLtetO12) + T500 + X + 
J23119 + cisRAJ11 + B + cRMIR11 + S 
 
gaattcAAAAAAAATCCTTAGCTTTCGCTAAGGATAATTGTGAGCGGATAAC
AATTGACATTGTGAGCGGATAACAAGATACTGAGCACGGGAGGGTTGA
TTGTGTGAGTCTGTCACAGTTCAGCGGAAACGTTGATGCTGTGACAGAT
TTATGCGAGGCGTGCTCAGTATCTCTATCACTGATAGGGATGTCAAACT
CTATCAATGATAGAGTgagcacCAAAGCCCGCCGAAAGGCGGGCTTTTCT
GTtctagaTTGACAGCTAGCTCAGTCCTAGGTATAATGCTAGCCCTCGCAT
AATTTCACTTCTTCAATCCTCCCGTTAAAGAGGAGAAATTATGAATGggat
ccGGGAGGGTTCTGTCACTTAATTATTCGAGGCAATCGTTAGGAGATAG
AGCTATGactagt 
 
Design of orthogonal riboregulators 
pMIR1.  
XOR11: C+E+rrnc (rev)+transRaj11 (rev)+ PLlacO12(rev)+ spacer+J23119 
+cisMI11+S+Nc 
atcgatgaattcAAAAAAAATCCTTAGCTTTCGCTAAGGATGCCTCGCATAAAT
CTGTCACAGCATCAACGTTTCCGCTGAACTGTGACAGACTCACACAATC
AACCCTCCCGTGCTCAGTATCTTGTTATCCGCTCACAATGTCAATGTTAT
CCGCTCACATTTATGCTAGCCAATTGATGCATTTGACAGCTAGCTCAGT
CCTAGGTATAATGCTAGCGGGAGGGTTCTGTCACTTAATTATTCGAGGC
AATCGTTAGGAGATAGAGCATATGactagtccatgg 
pMIR 
C+E + 
rrnc(rev)+transMiraj11(rev)+PLtetO12(rev)+spacer+J23119+cisRaj11+S+Nc 
atcgatgaattcAAAAAAAATCCTTAGCTTTCGCTAAGGATGGGAGGGTTGAT
TGTGTGAGTCTGTCACAGTTCAGCGGAAACGTTGATGCTGTGACAGATT
TATGCGAGGCGTGCTCAGTATCTCTATCACTGATAGGGATGTCAAACTC
TATCAATGATAGAGTGCTAGCCAATTGATGCATTTGACAGCTAGCTCAG
TCCTAGGTATAATGCTAGCCCTCGCATAATTTCACTTCTTCAATCCTCCC
GTTAAAGAGGAGAAATTATGAATGactagtccatgg 
 
 
 191 
 
Design sequence of Plasmid antiRAJ11(MIRAJ11) 
 
 E-X-revcom(PLtetO1-tRMIR11-T500)-N-M-Ns-PLlacO1-cRMIR11-S- 
gaattcgcggccgcttctagagACAGAAAAGCCCGCCTTTCGGCGGGCTTTGGGG
AGGGTTGATTGTGTAAGTCTGTCACAGTTCAGCGGAAACGTTGATGCTG
TGACAGATTTATGCGAGGCGTGCTCAGTATCTCTATCACTGATAGGGAT
GTCAATCTCTATCACTGATAGGGAgctagccaattgatgcatATAAATGTGAGCG
GATAACATTGACATTGTGAGCGGATAACAAGATACTGAGCACGGGAGG
GTTCTGTCACTTAATTATTCGAGGCAATCGTTAGGAGATAGAGCATATGa
ctagt 
Schematic of the final of ribozyme based ambisense 
riboregulator 
 
EcoRI +Rev(Ttonb term) + Rev(LAA) + Rev(mRFP)+ LacO + XbaI + 
Rev(cisRaj11)+Rev(J233119)+ NsiI + PLtetO12 +Rev (rnpB 
term)+Raj11sRNA+rrnC term + Rev (PLlacO1)+J23100+ cis_antiRaj11 
+SpeI +sfGFP + LAA + rrfB term+ PstI 
 
Sequence of the final of ribozyme based ambisense 
riboregulator 
 
5’-
gaattcGAAAACCTCGCGCCTTACCTGTTGAGTAATAGTCAAAAGCCTCCG
GTCGGAGGCTTTTGACTTTCTGCTTACTGAATTTCGGTGTTATCAAGCG
GCCAGGGCGTAGTTTTCATCGTTGGCAGCGCTGGTagcaccggtggagtgacg
accttcagcacgttcgtactgttcaacgatggtgtagtcttcgttgtgggaggtgatgtccagtttgatgtcggtt
ttgtaagcacccggcagctgaaccggttttttagccatgtaggtggttttaacttcagcgtcgtagtgaccacc
gtctttcagtttcagacgcattttgatttcacctttcagagcaccgtcttccgggtacatacgttcggtggaagct
tcccaacccatggtttttttctgcataaccggaccgtcggacgggaagttggtaccacgcagtttaactttgta
gatgaactcaccgtcttgcagggaggagtcctgggtaacggtaacaacaccaccgtcttcgaagttcata
acacgttcccatttgaaaccttccgggaaggacagtttcaggtagtccgggatgtcagccgggtgtttaacg
taagctttggaaccgtactggaactgcggggacaggatgtcccaagcgaacggcagcggaccacctttg
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gtaactttcagtttagcggtctgggtaccttcgtacggacgaccttcaccttcaccttcgatttcgaactcgtga
ccgttaacggaaccttccatacgaactttgaaacgcatgaactctttgataacgtcttcggaggaagcATT
GTGAGCGGATAACAAtctagaCATTCATAATTTCTCCTCTTTAACGGGAGG
ATTGAAGAAGTGAAATTATGCGAGGGCTAGCATTATACCTAGGACTGAG
CTAGCTGTCAAatgcatACTCTATCATTGATAGAGTTTGACATCCCTATCA
GTGATAGAGATACTGAGCACAAAAGCAAAAACCCGCCGAAGCGGGGGG
AGGGTTGATTGTGTGAGTCTGTCACAGTTCAGCGGAAACGTTGATGCTG
TGACAGATTTATGCGAGGCATCCTTAGCGAAAGCTAAGGATTTTTTTTGT
GCTCAGTATCTTGTTATCCGCTCACAATGTCAATGTTATCCGCTCACATT
TATtctagaTTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAGCGGGAGG
GTTCTGTCACTTAATTATTCGAGGCAATCGTTAGGAGATAGAGCATATGa
ctagtcgtaaaggcgaagagctgttcactggtgtcgtccctattctggtggaactggatggtgatgtcaacg
gtcataagttttccgtgcgtggcgagggtgaaggtgacgcaactaatggtaaactgacgctgaagttcatct
gtactactggtaaactgccggtaccttggccgactctggtaacgacgctgacttatggtgttcagtgctttgct
cgttatccggaccatatgaagcagcatgacttcttcaagtccgccatgccggaaggctatgtgcaggaac
gcacgatttcctttaaggatgacggcacgtacaaaacgcgtgcggaagtgaaatttgaaggcgataccct
ggtaaaccgcattgagctgaaaggcattgactttaaagaagacggcaatatcctgggccataagctgga
atacaattttaacagccacaatgtttacatcaccgccgataaacaaaaaaatggcattaaagcgaatttta
aaattcgccacaacgtggaggatggcagcgtgcagctggctgatcactaccagcaaaacactccaatc
ggtgatggtcctgttctgctgccagacaatcactatctgagcacgcaaagcgttctgtctaaagatccgaac
gagaaacgcgatcatatggttctgctggagttcgtaaccgcagcgggcatcacgcatggtatggatgaac
tgtacaaaGCTAGCGCAGCGAACGACGAAAATTACGCCCTGGCAGCGTAA
TAAGGGAACTGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGA
CTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTC 
TCCTGctgcag-3’ 
Sequence and plasmid list of chapter 3 
Tabe of content and plasmid sequences 
Table 1: Sequences of the cooperative sRNA systems designed in this work. 
Dot- bracket structures are also shown. The seed region for the interaction 
between the two sRNAs (CoopA and CoopB) is shown in cyan. The seed 
region for the interaction between the sRNA complex and the 5’ UTR 
(CoopU) is shown in red. In CoopU, the RBS is shown in yellow and the start 
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codon in green. The transcription terminator T500 (efficiency > 90%) was 
used in CoopA, shown in dark red, and the terminator TrrnC (efficiency > 
90%) or B1002 (efficiency about 90%) in CoopB,..  
Sequence of coop11. (Rev coop11A with T500)+( PLlacO1)+ (Rev coop11 B 
with Trrnc + PLtetO1 rev) +  PrJ23119+ coop11U+ sfGFPLAA  +kanR 
+pSC101 mutated 
gaattcAAAAAAAATCCTTAGCTTTCGCTAAGGATGCCTCGCATAAATCTGT
CACAGCATCAACGTTGTGCTCAGTATCTTGTTATCCGCTCACAATGTCA
ATTGTTATCCGCTCACAATTcaattgACAGAAAAGCCCGCCTTTCGGCGGG
CTTTGTCCGCTGAACTGTGACAGACTCACACAATCAACCCTCCCGTGCT
CAGTATCTCTATCACTGATAGGGATGTCAAACTCTATCAATGATAGAGTa
tgcattctagaTTGACAGCTAGCTCAGTCCTAGGTATAATGCTAGCCCTCGCA
TAATTTCACTTCTTCAATCCTCCCGTTAAAGAGGAGAAATTATGAATGaC
TAGTCGTAAAGGCGAAGAGCTGTTCACTGGTGTCGTCCCTATTCTGGTG
GAACTGGATGGTGATGTCAACGGTCATAAGTTTTCCGTGCGTGGCGAG
GGTGAAGGTGACGCAACTAATGGTAAACTGACGCTGAAGTTCATCTGTA
CTACTGGTAAACTGCCGGTACCTTGGCCGACTCTGGTAACGACGCTGA
CTTATGGTGTTCAGTGCTTTGCTCGTTATCCGGACCATATGAAGCAGCA
TGACTTCTTCAAGTCCGCCATGCCGGAAGGCTATGTGCAGGAACGCAC
GATTTCCTTTAAGGATGACGGCACGTACAAAACGCGTGCGGAAGTGAA
ATTTGAAGGCGATACCCTGGTAAACCGCATTGAGCTGAAAGGCATTGAC
TTTAAAGAAGACGGCAATATCCTGGGCCATAAGCTGGAATACAATTTTA
ACAGCCACAATGTTTACATCACCGCCGATAAACAAAAAAATGGCATTAA
AGCGAATTTTAAAATTCGCCACAACGTGGAGGATGGCAGCGTGCAGCT
GGCTGATCACTACCAGCAAAACACTCCAATCGGTGATGGTCCTGTTCTG
CTGCCAGACAATCACTATCTGAGCACGCAAAGCGTTCTGTCTAAAGATC
CGAACGAGAAACGCGATCATATGGTTCTGCTGGAGTTCGTAACCGCAG
CGGGCATCACGCATGGTATGGATGAACTGTACAAAGCTAGCGCAGCGA
ACGACGAAAATTACGCCCTTGCAGCGTAATAACTGCAggagtcactaagggtta
gttagttagattagcagaaagtcaaaagcctccgaccggaggcttttgactaaaacttcccttggggttatc
attggggctcactcaaaggcggtaatcagataaaaaaaatccttagctttcgctaaggatgatttctgctagt
attattagaaaaactcatcgagcatcaaatgaaactgcaatttattcatatcaggattatcaataccatattttt
gaaaaagccgtttctgtaatgaaggagaaaactcaccgaggcagttccaaagaatggcaaggtcctggt
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aacggtctgcgattccgacccgtccaacatcaatacaacctattaatttcccctcgtcaaaaataaggttatc
aagtgagaaatcaccatgagtgacgactgaatccggtgagaatggcaagagcttgtgcatttctttccaga
cttgttcaacaggccagccattacgctcgtcatcaaaatcactcgcatcaaccaaaccgttattcatgcgtg
attgcgcctgagcaagacgaaatacacgatcgctgttaaaaggacaattacaaacaggaatcgaatgta
accggcgcaggaacacggccagcgcatcaacaatattttcacctgaatcaggatattcttctaatacctgg
aaggctgttttcccaggaatcgcggtggtgagtaaccacgcatcatcaggagtacggataaaatgcttgat
ggtcgggagaggcataaactccgtcagccagttgagacggaccatctcatctgtaacatcattggcaacg
ctacctttgccatgtttcagaaacaactctggcgcatcgggcttcccatacaagcgatagattgtcgcacctg
attgcccgacattatcgcgagcccatttatacccatataaatcagcgtccatgttggagtttaagcgcggac
gggagcaagacgtttcccgttgaatatggctcataacaccccttgtattactgtttatgtaagcagacagtttt
attgttcatgatgatatatttttatcttgtgcaatgtaacatcagagattttgagacacaacgtggctttgttgaat
aaatcgaacttttgctgagttgaaggatcagctctagtagttacattgtcgatctgttcatggtgaacagcttta
aatgcaccaaaaactcgtaaaagctctgatgtatctatcttttttacaccgttttcatctgtgcatatggacagttt
tccctttgatatctaacggtgaacagttgttctacttttgtttgttagtcttgatgcttcactgatagatacaagagc
cataagaacctcagatccttccgtatttagccagtatgttctctagtgtggttcgttgtttttgcgtgagccatgag
aacgaaccattgagatcatgcttactttgcatgtcactcaaaaattttgcctcaaaactggtgagctgaattttt
gcagttaaagcatcgtgtagtgtttttcttagtccgttacgtaggtaggaatctgatgtaatggttgttggtattttg
tcaccattcatttttatctggttgttctcaagttcggttacgagatccatttgtctatctagttcaacttggaaaatca
acgtatcagtcgggcggcctcgcttatcaaccaccaatttcatattgctgtaagtgtttaaatctttacttattggt
ttcaaaacccattggttaagccttttaaactcatggtagttattttcaagcattaacatgaacttaaattcatcaa
ggctaatctctatatttgccttgtgagttttcttttgtgttagttcttttaataaccactcataaatcctcatagagtatt
tgttttcaaaagacttaacatgttccagattatattttatgaatttttttaactggaaaagataaggcaatatctctt
cactaaaaactaattctaatttttcgcttgagaacttggcatagtttgtccactggaaaatctcaaagcctttaa
ccaaaggattcctgatttccacagttctcgtcatcagctctctggttgctttagctaatacaccataagcattttc
cctactgatgttcatcatctgagcgtattggttataagtgaacgataccgtccgttctttccttgtagggttttcaat
cgtggggttgagtagtgccacacagcataaaattagcttggtttcatgctccgttaagtcatagcgactaatc
gctagttcatttgctttgaaaacaactaattcagacatacatctcaattggtctaggtgattttaatcactatacc
aattgagatgggctagtcaatgataattacatgtccttttcctttgagttgtgggtatctgtaaattctgctagacc
tttgctggaaaacttgtaaattctgctagaccctctgtaaattccgctagacctttgtgtgttttttttgtttatattca
agtggttataatttatagaataaagaaagaataaaaaaagataaaaagaatagatcccagccctgtgtat
aactcactactttagtcagttccgcagtattacaaaaggatgtcgcaaacgctgtttgctcctctacaaaaca
gaccttaaaaccctaaaggcttaagtagcaccctcgcaagctcgggcaaatcgctgaatattccttttgtctc
cgaccatcaggcacctgagtcgctgtctttttcgtgacattcagttcgctgcgctcacggctctggcagtgaat
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gggggtaaatggcactacaggcgccttttatggattcatgcaaggaaactacccataatacaagaaaag
cccgtcacgggcttctcagggcgttttatggcgggtctgctatgtggtgctatctgactttttgctgttcagcagtt
cctgccctctgattttccagtctgaccacttcggattatcccgtgacaggtcattcagactggctaatgcaccc
agtaaggcagcggtatcatcaacaggcttacccgtcttactgtccctagtgcttggattctcaccaataaaa
aacgcccggcggcaaccgagcgttctgaacaaatccagatggagttctgaggtcattactggatctatca
acaggagtccaagcgagctcgtaaacttggtctgacagctctagctccggcaaaaaaacgggcaaggt
gtcaccaccctgccctttttctttaaaaccgaaaagattacttcgcgtttgccacctgacgtctaagaaaagg
aatattcagcaatttgcccgtgccgaagaaaggcccacccgtgaaggtgagccagtgagttgattgctac
gtaattagttagttagcccttagtgact 
Table1 
Syste
m 
coop
2 
Sequence 
Coop
A2 
(with 
T500
)  
 
TGGCGGCGCAGCGTCCGGCCCGCCTCACATTTGCTCAACCAAA
GC 
CCGCCGAAAGGCGGGCTTTTCTGT 
Coop
B2 
(with 
Trrn
C 
ACTGGCGCGAAATGTAGAGGTGGGCCGGACGAATCCTTAGCGA
AAGC 
TAAGGATTTTTTTT 
cooU
2 
ACATCGCAGGTTTCTGCCTGCCTGCGCCGCCACACAGTAGGAG
AAATTCGATATG... 
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Coop
1A 
(with 
T500
)  
AATTTATTGAGGACGCTGCTTGTACGCTCTCGTATTGACGGCAC
CCGCGTCGATGTG AGGGACTTGG  
 
Coop
1B 
(with 
B100
2) 
CAAGTCCGTGAAGTGTACGGGCAGCTTGATATTTCGACCAGTTG
GAACTATTAATTTGGGACCA TTCATAGTGGTTCCGAAG  
 
Coop
1U 
AGTTCCGACGGGTCTCCTCTTTCGACTCCGCTTGAAAGAGG 
AGGTTTGTCATATG  
 
  
 
Table  Strains and plasmids used in this work.  
 
Strains or plasmids Features Ref. 
E. coli DH5  Commercial Invitrogen 
E. coli DH5 -Z1 Commercial (DH5   lacIQ, PN25-tetR, SpR) Clontech 
E. coli MG1655-Z1 lacIQ, PN25-tetR, SpR Gifted by 
M.B. 
Elowitz 
ptrigR2 pSC101m ori, kanR, sfGFP-LAA This work 
ptrigR2St pSC101m ori, kanR, sfGFP This work 
ptrigR1 pSC101m ori, kanR, sfGFP-LAA This work 
ptrigR11 pSC101m ori, kanR, sfGFP-LAA This work 
ptrigR11St pSC101m ori, kanR, sfGFP This work 
ptrigR31 pSC101m ori, kanR, sfGFP-LAA This work 
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ptrigR32 pSC101m ori, kanR, sfGFP-LAA This work 
pRAJ11 pUC ori, ampR-kanR, GFPmut3b [1] 
ptrigR31Hfq pSC101m ori, kanR, sfGFP-LAA This work 
ptrigR31Fusion pSC101m ori, kanR, sfGFP-LAA This work 
ptrigR11/2 sRNAs from system trigR11, 5' UTR from 
system trigR2 
pSC101m ori, kanR, sfGFP-LAA 
 
This work 
ptrigR2/11 sRNAs from system trigR2, 5' UTR from 
system trigR11 
pSC101m ori, kanR, sfGFP-LAA 
 
This work 
ptrigR31FFL pUC ori, ampR, sfGFP-LAA 
(J23119:SRRb31) 
This work 
 
Table 5 Creating single copy RNA switches 
pTKRED  pSC101 low copy, SpR, Temp 
sensitive   
This work 
pTK/CS P15A, CamR landing pad  This work 
pTKIP  pMB1 ampR , MCS site  This work 
pTK/CS-landing pad P15A, CamR landing pad in ygce  This work 
pTKIP-RAJ11 pMB1 ampR, RAJ11 This work 
E. coli MG1655-Z1 lacIQ, PN25-tetR, SpR Gifted by 
M.B. 
Elowitz 
 
 
 
 
 
 
 
